Next Article in Journal
Exosomes as Intercellular Messengers in Hypertension
Next Article in Special Issue
Serum Metabolomic and Lipidomic Profiling Reveals Novel Biomarkers of Efficacy for Benfotiamine in Alzheimer’s Disease
Previous Article in Journal
Interactions in Ternary Aqueous Solutions of NMA and Osmolytes—PARAFAC Decomposition of FTIR Spectra Series
Previous Article in Special Issue
Short Peptides Make a Big Difference: The Role of Botany-Derived AMPs in Disease Control and Protection of Human Health
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJMS
Volume 22
Issue 21
10.3390/ijms222111675
ijms-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Chronic Activation of AMPK Induces Mitochondrial Biogenesis through Differential Phosphorylation and Abundance of Mitochondrial Proteins in Dictyostelium discoideum

by
Malgorzata Heidorn-Czarna
1,2,*,
Herbert-Michael Heidorn
1,
Sanjanie Fernando
3,†,
Oana Sanislav
3,
Wieslawa Jarmuszkiewicz
4,
Rupert Mutzel
1 and
Paul R. Fisher
3
1
Department of Biology, Chemistry, Pharmacy, Institute for Biology-Microbiology, Freie Universität Berlin, 14195 Berlin, Germany
2
Department of Cellular Molecular Biology, Faculty of Biotechnology, University of Wroclaw, 50-383 Wroclaw, Poland
3
Discipline of Microbiology, Department of Physiology, Anatomy and Microbiology, School of Life Sciences, College of Science, Health and Engineering, La Trobe University, Bundoora, VIC 3086, Australia
4
Laboratory of Mitochondrial Biochemistry, Department of Bioenergetics, Faculty of Biology, Adam Mickiewicz University, 61-614 Poznan, Poland
*
Author to whom correspondence should be addressed.
†
The author passed away.
Int. J. Mol. Sci. 2021, 22(21), 11675; https://doi.org/10.3390/ijms222111675
Submission received: 28 September 2021 / Revised: 22 October 2021 / Accepted: 26 October 2021 / Published: 28 October 2021
(This article belongs to the Special Issue Biological Systems at the Protein Level 2.0)
Browse Figures
Versions Notes

Abstract

:
Mitochondrial biogenesis is a highly controlled process that depends on diverse signalling pathways responding to cellular and environmental signals. AMP-activated protein kinase (AMPK) is a critical metabolic enzyme that acts at a central control point in cellular energy homeostasis. Numerous studies have revealed the crucial roles of AMPK in the regulation of mitochondrial biogenesis; however, molecular mechanisms underlying this process are still largely unknown. Previously, we have shown that, in cellular slime mould Dictyostelium discoideum, the overexpression of the catalytic α subunit of AMPK led to enhanced mitochondrial biogenesis, which was accompanied by reduced cell growth and aberrant development. Here, we applied mass spectrometry-based proteomics of Dictyostelium mitochondria to determine the impact of chronically active AMPKα on the phosphorylation state and abundance of mitochondrial proteins and to identify potential protein targets leading to the biogenesis of mitochondria. Our results demonstrate that enhanced mitochondrial biogenesis is associated with variations in the phosphorylation levels and abundance of proteins related to energy metabolism, protein synthesis, transport, inner membrane biogenesis, and cellular signalling. The observed changes are accompanied by elevated mitochondrial respiratory activity in the AMPK overexpression strain. Our work is the first study reporting on the global phosphoproteome profiling of D. discoideum mitochondria and its changes as a response to constitutively active AMPK. We also propose an interplay between the AMPK and mTORC1 signalling pathways in controlling the cellular growth and biogenesis of mitochondria in Dictyostelium as a model organism.

1. Introduction

Mitochondria are involved in a vast array of biological processes, including energy transformation, calcium signalling, iron–sulphur (Fe-S) cluster biosynthesis, redox balance, the formation of reactive oxygen species (ROS) and the regulation of the apoptotic program, which are fundamental for cell metabolism and survival. The maintenance of mitochondrial homeostasis depends on the continuous fusion and fission of the mitochondrial network and a proper balance between mitochondrial biogenesis and degradation via mitophagy. The highly flexible nature of mitochondria allows the organelles to respond to cellular needs and environmental signals by changing their morphology, mass, content and dynamics.
Mitochondrial biogenesis is a complex and largely controlled process that occurs through the growth and division of existing mitochondria. It requires the increased and coordinated expression of nuclear and mitochondrial genomes, as well as synchronized import and the assembly of proteins and phospholipids in the mitochondrial membranes. The regulation of mitochondrial biogenesis occurs at transcriptional, translational and post-translational levels [1]. It depends on diverse signalling pathways which respond to hormonal, environmental or developmental signals and changes in the energy status of the cell [2]. Long-term exercise training, which is associated with energy deprivation and chronic metabolic stress, promotes mitochondrial biogenesis and increases muscle oxidative capacity to generate ATP [3,4,5]. Zong et al. [6] demonstrated that the reduction in the cellular ATP/AMP ratio resulted in the activation of AMP-activated protein kinase (AMPK) and increased mitochondrial biogenesis in mice skeletal muscles. The authors further reported that AMPK activation led to an increased expression of peroxisome proliferator-activated receptor γ coactivator 1α(PGC-1α) and calcium/calmodulin-dependent protein kinase IV (CaMKIV), both recognized as major regulators of mitochondrial biogenesis [7,8].
Phosphorylation is the most common reversible post-translational modification of proteins that alter their structural conformation and function, providing cells with a mechanism of response to chemical signals. AMPK is a serine/threonine protein kinase present in virtually all eukaryotic organisms [9,10,11,12,13,14]. It is a critical metabolic stress-responsive enzyme that acts at a central control point in cellular energy homeostasis. Upon low energy conditions, AMPK is activated and redirects metabolism by switching off the ATP-consuming anabolic pathways and switching on ATP-producing catabolic pathways through the reversible phosphorylation of multiple proteins to restore energy homeostasis [15,16]. Numerous studies have revealed the diverse roles of AMPK in regulating various cellular functions, such as cell growth and proliferation, metabolism, cell polarity and migration, and autophagy [17]. AMPK is also implicated in the regulation of mitochondrial homeostasis: mitochondrial biogenesis and mitophagy, as well as mitochondrial fission [18,19]. The phosphorylation of at least two known mitochondrial outer membrane proteins by AMPK (MFF—mitochondrial fission factor, and ACC2—acetyl-CoA carboxylase 2) [19,20,21] and the impact of AMPK on mitochondrial dynamics suggest that AMP-activated kinase colocalizes temporarily with the mitochondria. Indeed, it has been shown that, in humans, N-myristoylation of the AMPKβ subunit is essential for AMPK association with mitochondria and the removal of damaged mitochondria by mitophagy [22]. Interestingly, Miyamoto et al. [23] revealed the existence of AMPK at the mitochondria, independently from its cytosolic localization, using organelle-specific small-peptide probes for AMPK activity.
Research on the role of AMPK on mitochondrial homeostasis has so far focused mainly on mammalian cells and AMPK as a potential target for treating metabolic and cardiovascular diseases and cancer. In this work, we used the cellular slime mould Dictyostelium discoideum, an established eukaryotic model for studying mitochondrial biology and disease [11,24,25,26], to provide insight into how AMPK regulates the biogenesis of mitochondria. Previous research documented that a D. discoideum strain, overexpressing the catalytic AMPKα subunit, suffered morphological and developmental alterations, which include decreased growth rate both on agar plates with bacterial food sources and in liquid medium, decreased phototaxis and thermotaxis, decreased stalk length and increased stalk width, as compared with the wild-type, Ax2 cells [11,27]. These phenotypic abnormalities, seen in the AMPKα-overexpressing cells, were accompanied by enhanced mitochondrial biogenesis and increased intracellular levels of ATP [11].
The purpose of this study was to determine the impact of chronically activated AMPKα on the phosphorylation state and the abundance of mitochondrial proteins in D. discoideum cells, and thus to identify potential downstream protein targets that lead to increased mitochondrial biogenesis (Figure 1). By applying mass spectrometry-based phosphoproteomics of D. discoideum mitochondria, we identified 103 phosphoproteins and, among them, 35 proteins displayed variations in phosphorylation caused by chronic AMPKα activity. Differential phosphorylation levels showed proteins associated with oxidative phosphorylation (OXPHOS), transport, protein synthesis, and cellular signalling. Our 2-D PAGE proteomic analyses highlighted that, in D. discoideum, the enhanced mitochondrial biogenesis caused by the chronic activity of AMPKα is associated with an increased abundance of proteins related to protein translation and folding, amino acid degradation, mitochondrial inner membrane biogenesis and mtDNA metabolism. Our work is the first study reporting on the global phosphoproteome profiling of D. discoideum mitochondria and its changes as a response to enhanced mitochondrial biogenesis caused by constitutively active AMPK.

2. Results

2.1. Identification of Phosphorylation Sites in Dictyostelium Mitochondrial Proteins

To determine whether there is an impact of chronic AMPKα activation on the phosphorylation level of mitochondrial proteins in Dictyostelium cells, we first separated total mitochondrial proteins obtained from vegetative WT and AMPKα-overexpressing cells (HPF444) harvested at the exponential (E) and stationary (S) phases of growth by polyacrylamide gel electrophoresis in SDS (SDS-PAGE) (Figure 2). To selectively detect mitochondrial phosphoproteins, we stained the gel with Pro-Q Diamond dye, which discriminates between phosphorylated and non-phosphorylated proteins in acrylamide gels [28,29]. As demonstrated in Figure 2A, the phosphoproteins were explicitly detected in both WT and HPF444 mitochondria; however, a few protein bands showed either higher or lower intensity in the mutant compared to the WT, especially in the mitochondria of exponentially growing cells. Subsequent staining of the gels with Sypro Ruby dye excluded differences in the total protein of WT and HPF444 samples separated on that gel (Figure 2B). These data indicated the presence of differential phosphorylation of mitochondrial proteins in Dictyostelium AMPKα-overexpressing cells and prompted the performance of a large-scale quantitative comparative proteomic investigation of mitochondrial phosphoproteomes.
Consistent with our previous studies [11], we used exponentially growing cells of D. discoideum WT and HPF444 strains for mitochondrial phosphoproteome analyses. The phosphorylated proteins of purified mitochondrial fractions were investigated using titanium (IV) ion affinity chromatography (Ti4+-IMAC) for the selective enrichment of phosphopeptides in combination with an LC-MS/MS workflow for protein identification. Overall, our mitochondrial phosphoproteome analyses led to the identification of a total of 193 unique phosphopeptides, corresponding to 168 phosphorylation sites in 103 mitochondrial proteins in both WT and mutant cells (Figure 3, Table 1 and Table S1). We found 136 phosphoserine residues, 27 phosphothreonine residues, and only 5 phosphotyrosines among a total of 168 phosphorylation sites, which gives 81% pSer, 16% pThr and 3% pTyr (Figure 3B, Table 1 and Table S1). The identified phosphoproteins were categorized into the following nine functional groups: (1) OXPHOS, (2) OXPHOS complex regulation and assembly, (3) Genome repair and maintenance, (4) Protein synthesis, folding and stabilization, (5) Transport, (6) Signalling, (7) Metabolism, (8) Other functions, and (9) Unknown functions (Figure 3A, Table 1 and Table S1). The largest group of phosphoproteins (n = 47) was identified among the proteins with unknown functions (Table S1). These uncharacterized proteins were designated as proteins of unknown function because no detectable homology to proteins of known functions at the sequence and structure level was found to date. Notably, numerous phosphorylation sites (n = 20) were also identified among the OXPHOS I-V complexes, especially in the protein subunits of cytochrome b-c1 complex (complex III), cytochrome c oxidase (complex IV) and ATP synthase (complex V). The ATP synthase subunits 4 and beta were phosphorylated at multiple sites (n = 3 and n = 6, respectively), indicating that, in D. discoideum mitochondria, the ATP synthase complex is a target for phosphorylation-mediated regulation of its activity and/or structure. Interestingly, among the phosphorylated proteins functionally related to OXPHOS, we found F1F0-ATPase putative regulatory protein IF1 phosphorylated in serine 81 (Ser-81). This protein probably functions as the physiological inhibitor of the mitochondrial ATP synthase. In humans, the phosphorylation of IF1 in serine 39 (Ser-39) by mitochondrial protein kinase A (PKA) prevents its binding to the ATP synthase [30]. The identified phosphosite in Dictyostelium IF1 does not match the phosphorylated Ser residue in the human orthologue (Table S2).
Another important phosphorylated protein group was that of those involved in mitochondrial transport (n = 6) (Table 1). In this group, the most striking was mitochondrial substrate carrier family protein adenine nucleotide translocase (ANT), an orthologue of the human ADP/ATP translocase 1 (SLC25A4), with several phosphorylated serines (Ser-16, Ser-44, Ser-46, Ser-152, Ser-308) and threonines (Thr-47, Thr-150) identified. In humans, the ADP/ATP translocase 1 has also been phosphorylated at multiple sites. However, among phosphorylated amino acids identified in the D. discoideum ANT, only one (Ser-46) corresponds to the often-phosphorylated serine of the human orthologue (Ser-42) (Table S2) [PhosphoSitePlus, phosphosite.org]. Leucine zipper-EF-hand-containing transmembrane protein 1 (LETM1) and EF-hand domain-containing protein, which, similar to human LETM1, has been designated as a protein involved in the maintenance of mitochondrial osmotic balance, morphology, and viability [reviewed in 31], were found to be phosphorylated in threonine 282 (Thr-282) in D. discoideum mitochondria (Table 1). In mitochondria, LETM1 functions directly as a K+/H+ exchanger and indirectly modulates Ca2+ flux by affecting the Ca2+ cycle [31]. Recently, the phosphorylation of human LETM1 by PTEN-induced kinase 1 (PINK1) at Thr-192, which corresponds to Thr-178 in D. discoideum (Table S2), has been reported to facilitate calcium transport in neuronal mitochondria [32].
In the present study, we identified several phosphopeptides of a protein classified into mitochondrial metabolism, i.e., CDGSH iron–sulfur domain-containing protein, an orthologue of human mitoNEET-related protein 2 (Table 1). mitoNEET is a mitochondrial outer membrane protein that may be involved in the biogenesis of Fe-S clusters and electron transfer from FMNH2 to oxygen or coenzyme Q [33]. Notably, in Dictyostelium, this protein was found to be phosphorylated at serine 75 (Ser-75), which corresponds to the frequently phosphorylated Ser-83 in the human mitoNEET-related protein 2 (Table S2) [34,35,36]. Interestingly, in the mitochondria of D. discoideum, we found two sites for the phosphorylation of carbonic anhydrase, a kinase-regulated enzyme involved in ammonia detoxification and glucose metabolism in mammalian mitochondria [37,38].
Among the phosphoproteins we identified, a number are associated with various signalling pathways (Table 1), several of them carrying phosphorylated tyrosines, including glycogen synthase kinase-3 (GSK3), dual-specificity protein kinase SHKA, dual-specificity protein kinase SHKD, and a signal transducer and activator of transcription A (STATa). Phosphotyrosines constitute only a small proportion among the total number of phosphorylated amino acids identified in this work (5 pTyr in comparison to 27 pThr and 136 pSer) (Figure 3B). Here, we have shown that STATa is phosphorylated at the tyrosine residue at position 702 (Tyr-702) (Table 1), in agreement with previous studies by Kawata et al. [39]. In the group of proteins classified into the signalling category, we also included a protein similar to human Ragulator complex protein LAMTOR1; however, its direct mitochondrial colocalization has not been shown so far. We found that in Dictyostelium, this protein was phosphorylated at multiple sites (Thr-34, Ser-36, Ser-56, Ser-172). Among them, the Ser-36 residue corresponds to phosphorylated threonine (Thr-30) of the human orthologue (Supplemental Table S2) [36].

2.2. Protein Kinases Associated with Dictyostelium Mitochondria

Of all the identified mitochondrial phosphoproteins, the presence of several protein kinases (GSK3; Severin kinase, SvkA; SHKA and SHKD) in D. discoideum mitochondrial fractions is of great interest (Table 1 and Table 2). These kinases represent known kinase groups, i.e., CMGC (named after serine/threonine CDK, MAPK, GSK3, and CLK protein kinase families), STE (that includes serine/threonine Mitogen-Activated Protein Kinase families STE7, STE11, and STE20), and TKL (Tyrosine Kinase-Like protein kinase families) (Table 2) [40]. To date, none of these enzymes have been reported to be localized in Dictyostelium mitochondria; however, due to their similarity to the mammalian protein kinase groups, it is possible that at least a fraction of each of these enzymes resides in or on the slime mould mitochondria, or is functionally associated with them [41].
GSK3, which is an orthologue of the human GSK-3B kinase, has been detected as phosphorylated at serine 213 (Ser-213) and tyrosine 214 (Tyr-214) (Table 1). These phosphorylated amino acids correspond to the ubiquitously phosphorylated Ser-215 and Tyr-216 in human GSK-3B (Table S2). The same phosphorylated sites have been previously detected by Nichols et al. [42] in a global phosphoproteomic analysis of Dictyostelium vegetative cells responding to different chemoattractants, while the Ser-213 phosphorylation site was found in the study of Sugden et al. [43] as the response of Dictyostelium cells to differentiation-inducing factor-1 (DIF-1). Previously, it has been shown that in Dictyostelium, Tyr-214 and Tyr-220 of the GSK3 kinase are targets for cAMP-regulated phosphorylation and both sites are critical for GSK3 activation [44].
Additionally, we uncovered the phosphorylation of the SHKA kinase at the tyrosine residue 525 (Tyr-525), which corresponds to the Tyr-533 of its human orthologue TAK1 (MAP3K7) kinase, and the phosphorylation of SHKD at the tyrosine residue 739 (Tyr-739) (Table 1 and Table S2). To date, there is no information on the phosphorylation of these sites in D. discoideum or humans to date. Another identified kinase, Severin kinase (SvkA), which is also known as Hippo related kinase-svk (Krk-svk) [45], was phosphorylated at serine 375 (Ser-375) (Table 1). Previously, Ca2+-dependent autophosphorylation of SvkA in axenically growing Dictyostelium cells was demonstrated by Eichinger et al. [46]. This same phosphosite (Ser-375) in SvkA was also detected in Dictyostelium responding to cAMP by Nichols et al. [42].

2.3. Differential Phosphorylation Responses Caused by the Constitutive Hyperactivity of AMPKα

It has been known for some time that active AMPK promotes mitochondrial biogenesis [47]. In this work, the use of an MS-based quantitative phosphoproteomic approach has enabled us to detect differentially phosphorylated mitochondrial and mitochondria-associated proteins in response to chronically active AMPKα (Table 3 and Table S3). We focused on these phosphorylated proteins, which were identified in at least two biological replicates or with differential phosphosites identified in at least two peptides. These proteins are presumably downstream targets of the AMPK activity in Dictyostelium cells. Of all the identified differing phosphoproteins that were reproducibly quantified, only four proteins showed higher phosphorylation levels, and 31 had decreased phosphorylation levels in the HPF444 mitochondria, compared to WT mitochondria (Table 3 and Table S3). These differentially phosphorylated proteins were unexpectedly over-represented by uncharacterized proteins (2 with higher and 12 with lower phosphorylation level), making it difficult to fully interpret phosphorylation responses to disturbed AMPK signalling.
One of the proteins with a higher phosphorylation level in the mutant mitochondria is LETM1 (Leucine zipper-EF-hand-containing transmembrane protein 1), found phosphorylated at the Thr-282 residue (Table 3). Numerous findings using yeast, Drosophila, and mammalian mitochondria indicate the importance of LETM1 in mitochondrial K+ and Ca2+ homeostasis, and, thus, osmotic balance, affecting mitochondrial morphology, dynamics, and metabolism [48,49,50,51,52,53]. Additionally, it has also been suggested that, in yeast and mammals, LETM1 is a ribosomal-binding protein and has a function in mitochondrial translation, assembly of respiratory chain complexes, and respiration [54,55,56]. Whether LETM1 has a critical function in Dictyostelium mitochondria is currently unknown.
Another differentially modified protein, S5 DRBM domain-containing protein, had an increased phosphorylation level at serine 1587 (Ser-1587). In contrast, other identified phosphosites did not show differences in phosphorylation compared to the WT mitochondria (Table 1 and Table 3). The presence of the S5 DRBM domain and the similarity to other organisms indicate that this protein is likely Dictyostelium mitochondrial ribosomal protein S5, a component of a small 28S subunit. However, this must be confirmed. Nonetheless, these results indicate that the mitochondrial protein translation machinery components are most likely affected by chronically active AMPK to stimulate mitochondrial biogenesis.
Our data showed that, aside from a large number of uncharacterized proteins (n = 12), a decrease in steady-state phosphorylation level in response to the chronic activity of AMPK was also observed for the OXPHOS components (cytochrome c1, Ser-112; ATP synthase subunit gamma, Thr-85; ATP synthase subunit beta, Thr-69), chaperones and cochaperones (heat shock protein 70 kDa, Thr-655; DnaJ family protein, Ser-213), proteins involved in mitochondrial transport (mitochondrial substrate carrier family protein ANT, Ser-152, 308; mitochondrial substrate carrier family protein X, Ser-87) as well as an orthologue of human CISD3 (mitoNEET-related protein 2, Ser-75) (Table 3). All of these differentially phosphorylated mitochondrial proteins are either located in the inner membrane or matrix, except for mitoNEET-related protein 2, which by similarity to its human orthologue is likely located in the outer membrane of D. discoideum mitochondria [57].
Notably, among proteins with decreased phosphorylation levels, we also found non-mitochondrial proteins categorized in this study in the intracellular signalling category, such as SHKA protein kinase (Tyr-525), a protein similar to the human Ragulator complex protein LAMTOR1 (Thr-34, Ser-56, 172) and Ras-related protein Rab-1A (Ser-76) (Table 1 and Table 3). These proteins might constitute either upstream or downstream players of the AMPK pathways, regulating mitochondrial biogenesis and activity.

2.4. Effect of Chronically Elevated AMPKα Activity on the Abundance of the Mitochondrial Proteins

We also determined the effect of constitutive hyperactivity of the AMPKα subunit on the total mitochondrial proteome by identifying differentially expressed proteins using two-dimensional polyacrylamide gel electrophoresis (2-D PAGE). For the quantitative studies, mitochondrial proteins isolated from exponentially growing WT and HPF444 vegetative cells were analysed in three independent experiments (Figure 4A). Protein spots that showed a significant difference in abundance between HPF444 vs. WT (fold difference of ±1.2, p ≤ 0.05) were manually excised from Coomassie-stained master gels and identified by mass spectrometry. The identities of the differing proteins are presented in Table S4. Various energy-conserving proteins (the pyruvate dehydrogenase complex (PDH), the Krebs cycle and OXPHOS components), mitochondrial membrane biogenesis proteins and genome maintenance proteins, enzymes involved in protein synthesis, folding, and stabilization, diverse enzymes for amino acid and lipid metabolism, and some hypothetical proteins responded to the chronic activity of AMPK. Notably, our results show the remarkable plasticity of D. discoideum mitochondrial energy metabolism, as most of the identified enzymes of the PDH and the Krebs cycle, as well as enzymes involved in the degradation of amino acids and fatty acids, were significantly upregulated. On the other hand, the identified subunits of cytochrome b-c1 complex (Rieske Fe-S protein) and ATP synthase (ATP synthase subunits beta, OSCP and gamma) showed a strong down-regulation (Figure 4B). However, the most striking changes in abundance were observed among proteins involved in protein synthesis and folding. All of the identified mitochondrial ribosomal proteins (L17, S18 and S15P), mitochondrial translation elongation factors (G, Tu and Ts), as well as mitochondrial chaperones (chaperonin 60, Hsp70 and Hsp90 family protein TRAP1) were largely upregulated in the HPF444 mutant mitochondria (Figure 4B). These results indicate that enhanced mitochondrial protein synthesis and folding caused by overexpression of a constitutively active AMPK are among the critical signs of increased mitochondrial biogenesis. This assumption is also supported by an almost two-fold higher amount of mitofilin (Mic60), a protein essential for the mitochondrial inner membrane organization determining mitochondrial morphology and mitochondrial DNA (mtDNA) organization in mammals [58], as well as a 1.4-fold increase in the mitochondrial genome maintenance protein 101, which, in Saccharomyces cerevisiae, has been shown to bind directly to mtDNA and be essential for its maintenance and repair (Figure 4B, Table S4) [59].
Among these differentially expressed proteins, there were only four polypeptides which were also characterized by differential phosphorylation levels in the HPF444 mitochondria (Table 3). The Hsp70 protein was more abundant but showed lowered phosphorylation levels in HPF444. The hypothetical protein DDB0306113 displayed decreased abundance, but its phosphorylation level was significantly higher. For the ATP synthase gamma and beta subunits, which were less abundant in the mutant mitochondria, the level of phosphorylation varied in the same direction as protein amounts (Table 3, Tables S3 and S4).
Overall, these results indicate that, in Dictyostelium cells, the enhanced mitochondrial biogenesis due to chronic activity of AMPKα is associated with an increased abundance of proteins related to amino acid degradation, protein translation and folding, mitochondrial inner membrane biogenesis and mtDNA metabolism, as well as the differential phosphorylation of selected mitochondrial and mitochondria-related proteins, especially those involved in energy conservation, protein synthesis and cellular signalling.

2.5. Effect of Chronically Elevated AMPKα Activity on Mitochondrial Respiratory Function

After demonstrating that chronically elevated AMPK activity induces changes in the abundance and phosphorylation state of mitochondrial proteins in Dictyostelium, we tested the functional implications of these changes for mitochondrial respiration. Mitochondrial respiratory activity is regulated homeostatically by AMPK as part of an extended network of signalling pathways. This regulation is exerted at the level of transcription and the translation of mitochondrial proteins, the activity of key proteins involved, and the supply of oxidizable substrates. We hypothesized that chronically elevated AMPK activity would result in a new steady state, with elevated mitochondrial respiratory activity. To test this, we measured mitochondrial respiratory function using Seahorse respirometry, as described previously [60], using strains with different copy numbers of AMPK antisense-inhibition or overexpression constructs (Table S5) [11]. Both basal respiration rates (Figure 5A) and the maximum respiratory capacity of the electron transport chain (Figure 5B) increased significantly with increasing levels of AMPK alpha subunit expression. These results confirm that the observed changes to the mitochondrial phosphoproteome in AMPK overexpression strains are accompanied by elevated mitochondrial respiratory activity. The individual components of basal mitochondrial respiration (ATP synthesis and proton leak, Figure 5C,D) and maximum mitochondrial respiratory capacity (activity of Complexes I and II, Figure 5E,F) showed the same trends, but did not reach statistical significance (Table S5). This is likely because the sample sizes (number of strains) did not provide sufficient statistical power, given the necessarily smaller magnitude of each individual component and its correspondingly smaller effect on measured respiration rates.

3. Discussion

We performed the first profiling of the mitochondrial phosphoproteome in D. discoideum vegetative cells and its alterations in response to the chronic activation of the AMPK catalytic subunit. Using titanium ion affinity chromatography for selective phosphopeptide enrichment, in combination with high-performance LC-MS/MS, we identified 168 phosphorylation sites in 103 proteins of isolated mitochondria of both wild-type and mutant cells. The distribution between phosphorylated residues of the mitochondrial proteins was 81% pSer, 16% pThr and 3% pTyr, which is similar to the mitochondrial proteomes of mammalian cells, independent of the tissue or cell used for mitochondria isolation (82% pSer, 15% pThr, and 3% pTyr) [41], and less compared to mouse mitochondria (90% pSer, 9% pThr, 1% pTyr) [61]. All identified phosphorylated mitochondrial proteins are nuclear-encoded, suggesting that, in Dictyostelium, the phosphorylation of mitochondrial DNA-encoded proteins is rare.
There are a variety of functional consequences of phosphorylation and dephosphorylation of mitochondrial proteins, including their location, proper metabolism, the functionality of the Krebs cycle and OXPHOS, signalling, processes of fission and fusion, as well as the decision for mitophagy and apoptosis, reviewed in [62,63]. In this work, a substantial number of phosphorylation sites (besides the largest group of identified phosphosites among proteins with unknown function) was found within the OXPHOS components, particularly complexes III (subunits 6 and 8, heme and Rieske proteins), IV (subunits 4 and 5) and V (subunits 4, gamma, OSCP and beta) (Table 1). Despite a large amount of data showing the phosphorylation of most cytochrome b-c1 subunits, little is known about the functional significance of these modifications [64]. One of the two identified phosphosites in the cytochrome c1 (heme protein) subunit, Ser-112, was shown to be down-regulated in the Dictyostelium AMPKα-overexpressing mitochondria (Table 3).
There are multiple lines of evidence revealing that, in various organisms, the phosphorylation of the ATP synthase components impacts the activity and/or stability of this complex. In humans, several phosphosites of the ATP synthase beta subunit have been identified [65,66,67], and phosphorylation of some specific sites appears to be crucial for complex dimer assembly and activity. Kane et al. [68] used S. cerevisiae as a model system to understand the functional consequences of beta subunit phosphorylation in cardiac mitochondria. They showed that mutations of Thr-262 resulted in the down-modulation of the ATP synthase activity, while mutations of the Thr-58 impaired dimer formation, leading to decreased activity and impairing the crucial role of ATP synthase in cristae formation and overall mitochondrial shape [69]. Among the multiple phosphosites detected in the Dictyostelium ATP synthase beta subunit (Table 1), the phosphorylation of the Thr-69 residue was reduced in the HPF444 mutant (Table 3). Based on the comparison of the position of Thr-69 in the D. discoideum beta subunit to that of S. cerevisiae and human enzymes, it is highly probable that, in slime mould, the Thr-69 phosphosite is also located on the matrix-facing portion of the beta subunit, making it an accessible site for the rapid regulation of the ATP synthase complex assembly and phosphorylation-dependent modulation of its activity [68,70,71]. A decrease in the activity of the human ATP synthase has also been observed upon the phosphorylation of the gamma subunit (ATP5C1) by protein kinase C (PKC) [72]. Similar findings have been made in bovine heart mitochondria [73]. Interestingly, our phosphoproteomic data revealed a decreased level of Thr-85 phosphorylation in the gamma subunit of the ATP synthase in the AMPKα-overexpressing cells (Table 3). Despite the lack of data on the structure and phosphorylation-dependent regulation of ATP synthase activity in Dictyostelium mitochondria, it is tempting to speculate that the downregulation of phosphorylation of the specific sites of beta and gamma subunits in the HPF444 ATP synthase leads to its activation. This could maintain ATP synthase activity at the basal level, despite the significantly decreased abundance of the ATP synthase complex in the mutant mitochondria revealed by the 2-D PAGE proteomics in which beta, gamma and OSCP subunits were detected at greatly reduced levels (at fold changes −2.67, −1.47, −3.37, respectively) (Figure 4, Supplemental Table S4).
The phosphorylation of proteins imported from the cytosol into mitochondria can occur either before or during their import or inside mitochondria. In mammals, there are more than 30, while in yeast, at least 25 protein kinases are reported to be localized or functionally associated with mitochondria [62,63,74]. Here, we showed the presence of four different kinases associated with Dictyostelium mitochondria—GSK3, SvkA, SHKA, and SHKD (Table 2). In humans, the phosphorylation of the GSK-3B kinase at the Tyr-216 leads to the activation of this enzyme, and GSK-3B has been shown to translocate into mitochondria upon stress induction, where it is involved in the regulation of mitochondrial biogenesis and bioenergetics, mitochondrial motility, as well as mitochondria-induced apoptosis [75]. Here, the identification of the crucial phosphorylation site (Tyr-214) for the Dictyostelium GSK3 activity [44] suggests a similar activation of GSK3 through tyrosine phosphorylation under our conditions. However, this appears unrelated to AMPK, as we did not find any differences in the phosphorylation level between the AMPKα-overexpressing cells and the wild-type cells (Table 1 and Table 3).
The identification of SHKA, the orthologue of the human TAK1 kinase involved in the mitogen-activated protein kinase (MAPK) cascade pathway, in three independent Dictyostelium mitochondrial isolations, is of great importance. Even though there is no experimental data on the presence of TAK1 in mitochondria, there is a possibility of the transient mitochondrial colocalization of this kinase upon specific conditions. Recently, Hindi et al. [76] have shown that the deletion of TAK1 leads to the accumulation of enlarged or greatly interconnected mitochondria in the skeletal muscles of adult mice through the activation of AMPK. Furthermore, several studies revealed the direct role of TAK1 in the phosphorylation of AMPK [77,78] and the signalling of AMPK to activate TAK1 [79,80]. Our phosphoproteomic analysis revealed, in the HPF444 mitochondrial fractions, a lowered phosphorylation level of the Tyr-525 residue of SHKA, which corresponds to Tyr-533 of its human orthologue (Table 1, Table 3 and Table S2).
Previous studies have shown that the overexpression of the D. discoideum catalytic AMPKα subunit led to a decrease in the growth rate, severe morphological and developmental alterations, as well as increased intracellular levels of ATP and enhanced mitochondrial biogenesis [11,27]. A link between the AMPK activity and the maintenance of mitochondrial integrity/morphology and mitochondrial biogenesis has been well recognized [16]. However, a mechanism underlying AMPK-mediated mitochondrial biogenesis is not well understood. Activated AMPK phosphorylates and activates key protein substrates of catabolic pathways and inactivates proteins involved in biosynthetic pathways to restore cellular energy balance. There are now more than 60 validated downstream AMPK protein targets, including mitochondrial proteins (MFF, ACC2, cytochrome c, A-kinase anchor protein 1 (AKAP1)) [19,20,21,81,82,83]. The recognition of which Dictyostelium mitochondrial proteins are potential downstream targets that respond to the increased activity of AMPK appears to be challenging due to the identification of a large number of mitochondrial phosphoproteins of unknown function. Assuming that AMPK directly or indirectly phosphorylates a mitochondrial or mitochondria-related protein target to trigger mitochondria into biogenesis, we searched for proteins characterized by an increased phosphorylation level. We found only four such phosphoproteins (LETM1, S5 DRBM domain-containing protein, and two uncharacterized proteins), which could be potential substrates for AMPK activity (Table 3). By similarity to other organisms, LETM1 is presumably located in the Dictyostelium inner mitochondrial membrane, while S5 DRBM domain-containing protein resides in the matrix. This localization would hinder direct recognition by AMPK. However, the identification of enhanced phosphorylation of the LETM1 Thr-282 in the HPF444 mitochondria and the discovery that, in humans, LETM1 regulates mitochondrial calcium transport via PINK1-dependent phosphorylation [32] make this protein a potential regulatory target in the process of mitochondrial biogenesis. The role of mitochondrial calcium uptake in promoting mitochondrial biogenesis and mitochondrial network dynamics has recently been described [84,85].
In unicellular eukaryotes, including slime moulds, such as D. discoideum, cell growth is regulated mainly by the availability of nutrients, unlike metazoan organisms, which additionally require growth factors and cytokines to regulate nutrient supply and its availability for cell growth and proliferation [86]. In our studies, the wild-type and AMPKα-overexpressing cells were cultivated in a nutrient-rich medium, yet the decreased growth rate was observed with chronically active AMPK, which can mimic a situation in which there is a lack of nutrients. There are two major and highly conserved nutrient-sensing signalling pathways controlling cellular growth. One is AMPK itself and the second is the mTORC1 (mechanistic target of rapamycin complex 1) pathway. While AMPK suppresses cell growth by activating catabolic processes and inhibiting anabolic processes, mTORC1 promotes cell proliferation and growth by enhancing protein translation, lipid and nucleotide synthesis, and blocking autophagy [87]. In most eukaryotes, including Dictyostelium, there are two structurally and functionally distinct multiprotein mTOR complexes, rapamycin-sensitive mTORC1 and rapamycin-insensitive mTOR complex 2 (mTORC2), and both with mTOR serine/threonine protein kinase as a central catalytic component of the signalling hub [88,89,90].
There is an increasing body of evidence of the intrinsic crosstalk between the mTORC1 and AMPK pathways. The AMPK activation inhibits mTORC1, and this would have a major effect on conserving energy [87]. For example, mammalian AMPK directly phosphorylates two serines (Ser-722 and Ser-792) of RAPTOR, a structural component of the mTORC1, and these modifications inhibit mTORC1 activity [91]. One of the significant players of the mTORC1 pathways is LAMTOR1, a protein anchored to the lysosomal membrane and a crucial component of the Ragulator complex, which acts as a scaffold for the amino acid-activated mTORC1 [92,93]. It has been recognized that there is a pool of AMPK that permanently resides on the lysosomal membrane [94]. Upon glucose starvation, lysosome-bound AMPK is activated via the AXIN/LKB1 protein complex, and further, the AXIN/LKB1-AMPK complex binds to LAMTOR1, leading to the dissociation and inhibition of mTORC1. In our work, multiple phosphorylation sites of LAMTOR1 have been detected, and among them, three showed lowered phosphorylation levels in the mutant cells (Table 1 and Table 3). It is currently unknown whether the phosphorylation/dephosphorylation of LAMTOR1 affects the stability and activity of the mTORC1 complex.
Nutrients and, specifically, amino acids are the most effective stimuli for mTORC1 activation. In mammals, the Golgi-localized GTPase Rab1A acts as a conserved regulator of serine and glutamine signalling, which stimulates its binding to mTORC1 and the activation of the complex on the Golgi apparatus [95]. Interestingly, for its normal function, Rab1A needs to be phosphorylated. Levin et al. [96] demonstrated that the phosphorylation of Rab1 is executed by TAK1 kinase at the Thr-75 residue, which is essential for Rab1 activation. Our phosphoproteomic studies revealed a decreased level of phosphorylation of Rab1A at Ser-76, indicating that this protein has a reduced function in the HPF444 mutant cells (Table 3).
In this study, we found differentially phosphorylated proteins involved in the AMPK/mTORC1 signalling pathways (LAMTOR1, Rab1A, SHKA) in the Dictyostelium mitochondrial fractions and observed changes in the abundance of mitochondrial proteins involved in energy metabolism, protein synthesis, and membrane biogenesis. This suggests a possible mechanism involving an interplay between the AMPK and mTORC1 pathways in the AMPKα-overexpressing Dictyostelium cells, resulting in reduced cellular growth rate accompanied by enhanced mitochondrial biogenesis. The crosstalk between AMPK and mTORC1 in Dictyostelium during vegetative growth and development has been recently described [97]. In healthy cells, the activities of mTORC1 and AMPK are coordinated in a network of regulatory pathways. Here, we propose that chronically active AMPK leads to the inhibition of the mTORC1 pathway via dephosphorylation-dependent events including the SHKA-Rab1A-mTORC1 route and/or the AMPK-LAMTOR1-mTORC1 pathway (Figure 6). This could combine with AMPK’s direct inhibitory phosphorylation of the RAPTOR subunit of mTORC1 to inhibit its activity and produce a decrease in cell growth and division [97]. mTORC1 is known for stimulation of expression of OXPHOS proteins [98,99]; hence, it is likely that the downregulation of OXPHOS components in AMPKα-overexpressing Dictyostelium cells results from the inhibition of mTORC1 activity. Enhanced mitochondrial biogenesis is induced by as yet unidentified mitochondrial protein targets, which, upon direct or indirect phosphorylation by AMPK, leads to dramatic changes in the abundance and/or phosphorylation-dependent activity of mitochondrial proteins involved in energy metabolism, protein synthesis, and membrane biogenesis. These changes, in turn, lead to an increase in mitochondrial mass/membrane potential and cellular ATP levels [11], as well as an increase in mitochondrial basal and maximum respiration rates (Figure 5) in the AMPKα-overexpressing cells.

4. Materials and Methods

4.1. D. discoideum Strains and Culture Growth Conditions

The experiments were conducted with the D. discoideum wild-type (WT) strain, A × 2, and the AMPKαT transformant overexpressing the catalytic domain of the AMPKα subunit (snfA) derived therefrom (strain ID: DBS0238735, www.dictybase.org). The studied AMPKαT strain was previously described in Bokko et al. [11]. In this work, the stable clone HPF444 overexpressing AMPKαT has been used.
The D. discoideum cells were axenically grown in HL-5 medium (Formedium, Hunstanton, Norfolk, UK) [100], supplemented with 100 μg/mL ampicillin, and for the transformed line, additionally with 20 μg/mL geneticin (G-418). Cell suspensions were cultured at 22 °C on a rotary shaker at 150 rpm. The generation time of continuously agitated wild-type and HPF444 cultures was approximately 8–9 h and 10–11 h, respectively.

4.2. Mitochondria Isolation

Mitochondria were isolated from vegetative cells of WT and HPF444 collected at densities of 1.5–2.0 × 106/mL or 1.8–2.2 × 107/mL (exponential and stationary phase of growth, respectively). The cells were harvested by centrifugation at 700× g for 5 min at 4 °C and washed twice in cold Sorensen phosphate buffer (15 mM KH2PO4, 2 mM Na2HPO4, ×7H2O, pH 6.0). Cells were resuspended in ice-cold STEB buffer (200 mM sucrose, 20 mM Tris-Cl, 1 mM (ethylene glycol-bis(β-aminoethyl ether)-N,N,N′,N′-tetraacetic acid), EGTA, pH 8.0, supplemented with 0.2% defatted bovine serum albumin, BSA) in the amount of 1 mL STEB/1 × 108 cells and lysed in a waring blender. The extract of cells was centrifuged for 20 min at 27,000× g and 4 °C. The obtained pellet was then resuspended in ice-cold STEB buffer with BSA and centrifuged for 4 min at 400× g and 4 °C. The resulting supernatant was centrifuged for 10 min at 16,000× g and 4 °C. The obtained mitochondrial pellet was washed twice in a STEB buffer without BSA by centrifugation at 16,000× g for 10 min and 4 °C. Isolated crude mitochondria were resuspended at a density of 10 mg of proteins per 1 mL of STEB without BSA, applied onto a three-step sucrose gradient (4 mL 23%, 4 mL 32%, 2.5 mL 60%), and centrifuged at 150,000× g for 1 h at 4 °C. Purified mitochondria were washed twice in STEB at 16,000× g for 10 min and 4 °C to remove excess sucrose. The protein concentration of the mitochondrial samples was evaluated with the DC Protein Assay (Bio-Rad, Richmond, CA, USA), based on Lowry’s method [101].

4.3. Protein Sample Preparation for Phosphoproteome Identification with Mass Spectrometry

The mitochondrial pellets of WT and HPF444 that have been obtained from three independent biological replicates of the cells from the exponential phase of growth were resuspended in lysis buffer (8 M urea in 50 mM triethylammonium bicarbonate, pH 8.5, 1 mM sodium orthovanadate, one tablet of Complete mini EDTA-free mixture (Roche Applied Science, Mannheim, Germany), one tablet of PhosSTOP phosphatase inhibitor mixture (Roche Applied Science, Mannheim, Germany) per 10 mL of lysis buffer and lysed by 10 rapid passages through a 23-gauge hypodermic syringe needle and by sonication on ice. After centrifugation at 20,000× g for 30 min at 4 °C, the protein concentration was determined using the Bradford assay (Pierce, Rockford, IL, USA). Proteins were reduced with 2 mM dithiothreitol (DTT) at 56 °C for 25 min and then alkylated with 4 mM iodoacetamide at room temperature for 30 min in the dark. Proteins were then reduced again with 2 mM DTT at room temperature to prevent over-alkylation. A first enzymatic digestion step was performed in 8 M urea lysis buffer using Lys-C at 37 °C for 4 h (enzyme/substrate ratio 1:50). The samples were then diluted four times with 50 mM triethylammonium bicarbonate, pH 8.5, and digested overnight at 37 °C using trypsin (enzyme/substrate ratio 1:50). The digestion was quenched with 5% formic acid. The resulting peptides were chemically labelled using stable isotope dimethyl labelling as described before [102]. The protein digests from the wild-type and HPF444 were labelled as “Light” (L) and “Heavy” (H), respectively. An aliquot of each label was measured on a regular LC-MS/MS run, and samples were mixed 1:1 (L:H) based on their peptide intensities and dried down.

4.4. Phosphopeptide Enrichment

The specific enrichment of phosphopeptides before mass spectrometry analysis was prepared using monodisperse microsphere-based immobilized titanium (IV) ion affinity chromatography (Ti4+-IMAC). Ti4+-IMAC material was prepared as described in Zhou et al. [103]. The prepared Ti4+-IMAC beads were loaded onto GELoader tips (Eppendorf, Hamburg, Germany) using a C8 plug to approximately 1–2 cm length of material. The enrichment procedure consisted of the following steps: first, the Ti4+-IMAC material was pre-equilibrated twice with 50 μL of Ti4+-IMAC loading buffer (80% acetonitrile (ACN), 6% trifluoroacetic acid (TFA)). During the next step, each SCX fraction was resuspended in 50 μL of loading buffer and loaded onto the equilibrated GELoader tips. Then, the Ti4+-IMAC material was washed with 50 μL wash buffer A (50% ACN, 0.5% TFA, 200 mM NaCl) and subsequently with 50 μL wash buffer B (50% ACN, 0.1% TFA). Bound peptides were first eluted by 30 μL of 10% ammonia into 30 μL of 10% FA. Finally, the remaining peptides were eluted with 2 μL of 80% CAN and 2% FA. The collected eluate was further acidified by adding 3 μL of 100% FA and stored at −80 °C for LC-MS/MS analysis.

4.5. 1-D SDS-PAGE and Pro-Q Diamond Staining for Phosphoprotein Detection in Polyacrylamide Gels

One hundred micrograms of mitochondrial proteins of WT and HPF444 isolated from the cells from the exponential and stationary phases of growth were solubilized in Laemmli sample buffer and resolved by 12% sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) [104]. Following electrophoresis, the gels were incubated overnight in a fixing solution (40% v/v methanol, 10% v/v acetic acid). After several washing steps in bidistilled water, the gels were then stained with 1× diluted Pro-Q Diamond phosphoprotein gel stain (Thermo Fisher Scientific, Waltham, MA, USA) for 3 h in the dark at room temperature to detect phosphorylated mitochondrial proteins. After staining, the gels were incubated in a Pro-Q Diamond destain solution (Thermo Fisher Scientific) for a total of 1.5 h (three times 30 min) in the dark. The stained gels were then visualized using the FLA 2000 scanner (Fuji Photo Film, Tokyo, Japan) at wavelengths of 532 nm and 580 nm for excitation and emission, respectively. Following imaging, the gels were further incubated in SYPRO Ruby protein gel stain (Thermo Fisher Scientific, Waltham, MA, USA) overnight in the dark at room temperature to detect total proteins. After staining, the gels were washed in a wash solution (40% v/v methanol, 7% v/v acetic acid) for 45 min in the dark. Imaging of total mitochondrial proteins was performed using the FLA 2000 scanner at wavelengths of 473 nm for excitation and 520 nm for emission.

4.6. Two-dimensional Polyacrylamide Gel Electrophoresis Analysis and Protein Identification

Mitochondrial proteins of WT and HPF444 isolated from three independent biological replicates of exponentially growing cells were extracted with a lysis buffer (8 M urea, 2 M thiourea, 2% w/v amidosulfobetaine-14, 20 mM DTT, 30 mM Tris-HCl, pH 8.5, protease inhibitor cocktail (Complete mini EDTA-free mixture, Roche Applied Science, Mannheim, Germany) and precipitated using the 2-D Clean-Up Kit (GE Healthcare, Uppsala, Sweden) as described previously [105]. Four hundred micrograms of mitochondrial protein samples were mixed with rehydration solution (7 M urea, 2 M thiourea, 2% w/v amidosulfobetaine-14, 2% v/v IPG buffer 4–7 (GE Healthcare), 1.2% v/v De-streak solution (GE Healthcare, Uppsala, Sweden), 1% DTT) to a final volume of 340 μL and applied onto 18 cm ImmobilineTM DryStrips, pH 4–7 (GE Healthcare, Uppsala, Sweden). The mitochondrial proteins were resolved isoelectrically using an IPGphor isoelectric focusing unit (Amersham Pharmacia Biotech, Freiburg, Germany). Rehydration of the strips and isoelectric focusing (IEF) was conducted at 0 V for 1 h (rehydration), 30 V for 165 Vh (step), 60 V for 480 Vh (step), 200 V for 200 Vh (step), 500 V for 500 Vh (step), 8 kV for 8 kVh (gradient), 8 kV for 36 kVh (step) and 30 V for 150 Vh (step) to reach 45 kVh (total) at a maximum setting of 50 µA per strip. After IEF, the IPG strips were equilibrated for 25 min in 6 M urea, 50 mM Tris (pH 8.8), 2% w/v SDS and 30% v/v glycerol, supplemented with 65 mM DTT and then for a further 15 min in the same buffer except that DTT was replaced with 135 mM iodoacetamide [105]. After the equilibration step, the IPG strips were applied on the top of 12.5% acrylamide and 0.1% w/v N,N′-methylene-bis-acrylamide gels (22 × 20 cm). Second-dimensional electrophoresis was performed at 180 V for 6–7 h at 15 °C in a Protean II xi unit (Bio-Rad, Richmond, CA, USA). After electrophoresis, the gels were incubated for 2 h in a fixing solution (40% v/v methanol, 10% v/v acetic acid) and then stained overnight in the colloidal Coomassie G-250 solution at room temperature [106]. To enhance contrast, the Coomassie-stained gels were washed several times in bidistilled water and then incubated for 1 h in a destaining solution (10% v/v methanol, 2% v/v orthophosphoric acid) and stored in 5% v/v acetic acid. Three biological replicates of each mitochondrial protein sample were run independently on 2-D PAGE gels. The gels were scanned, and the generated TIFF images were analyzed using Delta 2-D Software 4.2 (DECODON, Greifswald, Germany) for normalization and statistical analysis. Protein spots that showed a significant difference in abundance between HPF444 vs. WT (fold difference of ±1.2, p ≤ 0.05.) were manually picked from the gels and designed for tryptic digestion and peptide extraction. The gel pieces were washed three times in a digestion buffer (50 mM triethylammonium bicarbonate, pH 8.5, 5% v/v ACN) and then incubated in 100% ACN to dehydrate the gels. In-gel tryptic digestion was performed with freshly activated trypsin (self-digestion-protected, sequencing-grade, Sigma-Aldrich, St.Louis, MO, USA) at a 12.5 µg/µL concentration in a digestion buffer. After rehydration of the gel pieces at 8 °C for 30 min, tryptic digestion was carried out overnight at 37 °C. The resulting peptides were extracted with 1% TFA for 30 min at room temperature with occasional shaking. A volume of 3 µL of the protein digest was transferred onto Prespotted AnchorChip plates with CHCA as a matrix, and the spots were briefly desalted with 10 mM dihydrogen ammonium phosphate in 0.1% TFA. The samples were analyzed by the Ultraflex II MALDI-TOF-TOF mass spectrometer (Bruker Daltonics, Bremen, Germany) using the TOF/MS-LIFT-MS/MS combined mode as described in Czarna et al. [105].

4.7. Seahorse Respirometry

A Seahorse Analyser (Agilent Technologies, Santa Clara, CA, USA) was used for the mitochondrial respiration assays as described previously [60]. Dictyostelium cells grown in HL-5 medium with shaking overnight were washed and resuspended in SIH (Formedium, Hunstanton, Norfolk, UK) media supplemented with 20 mM pyruvate and 5 mM glutamate, pH 7.4. Cells were then inoculated onto a 24-well cell culture plate, pre-treated with Matrigel, to ensure cell attachment during the assay. Basal oxygen consumption rates (OCR) were measured in the absence and presence of 10 μM N,N′-dicyclohexylcarbodimide (DCCD), ATP synthase inhibitor to estimate the contribution of the ATP-linked OCR (DCCD-sensitive OCR) and non-ATP-linked OCR (DCCD-resistant proton leak). Subsequently, 10 μM carbonyl cyanide 3-chlorophenol hydrazone (CCCP) was added to determine the maximum OCR. The mitochondrial inhibitors and reagents were then injected to estimate the contribution to the maximum OCR of each of the mitochondrial complexes, including alternative oxidase (AOX), in the following order: 20 μM rotenone, complex I inhibitor and either 10 μM antimycin A, complex III inhibitor or 1.5 mM benzohydroxamic acid (BHAM), AOX inhibitor. The residual (non-mitochondrial) respiration observed after complete blockage by mitochondrial electron transport inhibitors was included in the calculation of the respective OCR.

Supplementary Materials

The Supplementary Materials are available online at https://www.mdpi.com/article/10.3390/ijms222111675/s1.

Author Contributions

Conceptualization, M.H.-C., P.R.F. and R.M.; methodology, formal analysis, M.H-C., H.-M.H., S.F. and O.S.; investigation, M.H.-C., H.-M.H. and O.S.; resources, P.R.F. and R.M.; data curation, M.H.-C. and H.-M.H.; writing—original draft preparation, M.H.-C.; writing—review and editing, M.H.-C., W.J., R.M. and P.R.F.; visualization, M.H.-C.; supervision, P.R.F. and R.M.; project administration, M.H.-C.; funding acquisition, M.H.-C. All authors have read and agreed to the published version of the manuscript.

Funding

This research was supported by the Alexander von Humboldt Foundation and PRIME-XS Consortium (seventh Framework Programme of the European Union, Contract No. 262067-PRIME-XS) granted to M.H.-C.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data presented in this study are available on request from the corresponding author. The data are not yet publicly available due to the fact that the proteomics data were acquired and stored by a different organization and has not been deposited yet. The goal is having the data either deposited in a repository, or included as supplementary data, in case of publication.

Acknowledgments

M.H-C. was supported by a Humboldt Research Fellowship for Postdoctoral Researchers from the Alexander von Humboldt Foundation. The authors thank the PRIME-XS Consortium (seventh Framework Programme of the European Union) for performing mass spectrometry-based phosphoproteomics.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Zhang, Y.; Xu, H. Translational regulation of mitochondrial biogenesis. Biochem. Soc. Trans. 2016, 44, 1717–1724. [Google Scholar] [CrossRef] [Green Version]
  2. Dominy, J.E.; Puigserver, P. Mitochondrial biogenesis through activation of nuclear signaling proteins. Cold Spring Harb. Perspect. Biol. 2013, 5, a015008. [Google Scholar] [CrossRef]
  3. Williams, R.S.; Salmons, S.; Newsholme, E.A.; Kaufman, R.E.; Mellor, J. Regulation of nuclear and mitochondrial gene expression by contractile activity in skeletal muscle. J. Biol. Chem. 1986, 1, 376–380. [Google Scholar] [CrossRef]
  4. Hood, D.A. Invited review: Contractile activity-induced mitochondrial biogenesis in skeletal muscle. J. Appl. Physiol. 2001, 90, 1137–1157. [Google Scholar] [CrossRef] [PubMed]
  5. Zoladz, J.A.; Koziel, A.; Woyda-Ploszczyca, A.; Celichowski, J.; Jarmuszkiewicz, W. Endurance training increases the efficiency of rat skeletal mitochondria. Pflugers Archiv. Eur. J. Physiol. 2016, 468, 1709–1724. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  6. Zong, H.; Ren, J.M.; Young, L.H.; Pypaert, M.; Mu, J.; Birnbaum, M.J.; Shulman, G.I. AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation. Proc. Natl. Acad. Sci. USA 2002, 99, 15983–15987. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  7. Wu, Z.; Puigserver, P.; Andersson, U.; Zhang, C.; Adelmant, G.; Mootha, V.; Troy, A.; Cinti, S.; Lowell, B.; Scarpulla, R.C.; et al. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 1999, 98, 115–124. [Google Scholar] [CrossRef] [Green Version]
  8. Wu, H.; Kanatous, S.B.; Thurmond, F.A.; Gallardo, T.; Isotani, E.; Bassel-Duby, R.; Williams, R.S. Regulation of mitochondrial biogenesis in skeletal muscle by CaMK. Science 2002, 296, 349–352. [Google Scholar] [CrossRef]
  9. Thelander, M.; Olsson, T.; Ronne, H. Snf1-related protein kinase 1 is needed for growth in a normal day-night light cycle. EMBO J. 2004, 23, 1900–1910. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  10. Baena-Gonzalez, E.; Rolland, F.; Thevelein, J.M.; Sheen, J. A central integrator of transcription networks in plant stress and energy signalling. Nature 2007, 448, 938–942. [Google Scholar] [CrossRef]
  11. Bokko, P.B.; Francione, L.; Bandala-Sanchez, E.; Ahmed, A.U.; Annesley, S.J.; Huang, X.; Khurana, T.; Kimmel, A.R.; Fisher, P.R. Diverse cytopathologies in mitochondrial disease are caused by AMP-activated protein kinase signaling. Mol. Biol. Cell 2007, 18, 1874–1886. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  12. Hedbacker, K.; Carlson, M. SNF1/AMPK pathways in yeast. Front. Biosci. 2008, 13, 2408–2420. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Narbonne, P.; Roy, R. Caenorhabditis elegans dauers need LKB1/AMPK to ration lipid reserves and ensure long-term survival. Nature 2009, 457, 210–214. [Google Scholar] [CrossRef] [PubMed]
  14. Johnson, E.C.; Kazgan, N.; Bretz, C.A.; Forsberg, L.J.; Hector, C.E.; Worthen, R.J.; Onyenwoke, R.; Brenman, J.Y. Altered metabolism and persistent starvation behaviors caused by reduced AMPK function in Drosophila. PLoS ONE 2010, 5, e12799. [Google Scholar] [CrossRef] [Green Version]
  15. Hardie, D.G. AMP-activated/SNF1 protein kinases: Conserved guardians of cellular energy. Nat. Rev. Mol. Cell Biol. 2007, 8, 774–785. [Google Scholar] [CrossRef] [PubMed]
  16. Herzig, S.; Shaw, R.J. AMPK: Guardian of metabolism and mitochondrial homeostasis. Nat. Rev. Mol. Cell Biol. 2018, 19, 121–135. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  17. Vara-Ciruelos, D.; Dandapani, M.; Hardie, D.G. AMP-activated protein kinase: Friend or foe in cancer? Annu. Rev. Cancer Biol. 2020, 4, 1–16. [Google Scholar] [CrossRef] [Green Version]
  18. Egan, D.F.; Shackelford, D.B.; Mihaylova, M.M.; Gelino, S.; Kohnz, R.A.; Mair, W.; Vasquez, D.S.; Joshi, A.; Gwinn, D.M.; Taylor, R.; et al. Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy. Science 2011, 331, 456–461. [Google Scholar] [CrossRef] [Green Version]
  19. Toyama, E.Q.; Herzig, S.; Courchet, J.; Lewis, T.L., Jr.; Loson, O.C.; Hellberg, K.; Young, N.; Chen, H.; Polleux, F.; Chan, D.C.; et al. AMP-activated protein kinase mediates mitochondrial fission in response to energy stress. Science 2016, 351, 275–281. [Google Scholar] [CrossRef] [Green Version]
  20. Ducommun, S.; Deak, M.; Sumpton, D.; Ford, R.J.; Galindo, A.N.; Kussmann, M.; Viollet, B.; Steinberg, G.R.; Foretz, M.; Dayon, L.; et al. Motif affinity and mass spectrometry proteomic approach for the discovery of cellular AMPK targets: Identification of mitochondrial fission factor as a new AMPK substrate. Cell Signal. 2015, 27, 978–988. [Google Scholar] [CrossRef] [Green Version]
  21. Munday, M.R.; Campbell, D.G.; Carling, D.; Hardie, D.G. Identification by amino acid sequencing of three major regulatory phosphorylation sites on rat acetyl-CoA carboxylase. Eur. J. Biochem. 1988, 175, 331–338. [Google Scholar] [CrossRef] [PubMed]
  22. Liang, J.; Xu, Z.-X.; Ding, Z.; Lu, Y.; Yu, Q.; Werle, K.D.; Zhou, G.; Park, Y.-Y.; Peng, G.; Gambello, M.J.; et al. Myristoylation confers noncanonical AMPK functions in autophagy selectivity and mitochondrial surveillance. Nat. Commun. 2015, 6, 7926. [Google Scholar] [CrossRef] [PubMed]
  23. Miyamoto, T.; Rho, E.; Sample, V.; Akano, H.; Magari, M.; Ueno, T.; Gorshkov, K.; Chen, M.; Tokumitsu, H.; Zhang, J.; et al. Compartmentalized AMPK signaling illuminated by genetically encoded molecular sensors and actuators. Cell Rep. 2015, 11, 657–670. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Kotsifas, M.; Barth, C.; De Lozanne, A.; Lay, S.T.; Fisher, P.R. Chaperonin 60 and mitochondrial disease in Dictyostelium. J. Muscle Res. Cell Motil. 2002, 23, 839–852. [Google Scholar] [CrossRef]
  25. Francione, L.; Fisher, P.R. Heteroplasmic mitochondrial disease in Dictyostelium discoideum. Biochem. Pharmacol. 2011, 82, 1510–1520. [Google Scholar] [CrossRef]
  26. Pearce, X.G.; Annesley, S.J.; Fisher, P.R. The Dictyostelium model for mitochondrial biology and disease. Int. J. Dev. Biol. 2019, 63, 497–508. [Google Scholar] [CrossRef] [Green Version]
  27. Maurya, R.; Kumar, R.; Saran, S. Dictyostelium AMPKα regulates aggregate size and cell-type patterning. Open Biol. 2017, 7, 170055. [Google Scholar] [CrossRef] [Green Version]
  28. Steinberg, T.H.; Agnew, B.J.; Gee, K.R.; Leung, W.-Y.; Goodman, T.; Schulenberg, B.; Hendrickson, J.; Beechem, J.M.; Haugland, R.P.; Patton, W.F. Global quantitative phosphoprotein analysis using multiplexed proteomics technology. Proteomics 2003, 3, 1128–1144. [Google Scholar] [CrossRef] [PubMed]
  29. Schulenberg, B.; Aggeler, R.; Beechem, J.M.; Capaldi, R.A.; Patton, W.F. Analysis of steady-state protein phosphorylation in mitochondria using a novel fluorescent phosphosensor dye. J. Biol. Chem. 2003, 278, 27251–27255. [Google Scholar] [CrossRef] [Green Version]
  30. Garcia-Bermudez, J.; Sanchez-Arago, M.; Soldevilla, B.; Del Arco, A.; Nuevo-Tapioles, C.; Cuezva, J.M. PKA phosphorylates the ATPase inhibitory factor 1 and inactivates its capacity to bind and inhibit the mitochondrial H-ATP synthase. Cell Rep. 2015, 12, 2143–2155. [Google Scholar] [CrossRef] [Green Version]
  31. Austin, S.; Nowikovsky, K. LETM1: Essential for mitochondrial biology and cation homeostasis? Trends Biochem. Sci. 2019, 44, 648–658. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  32. Huang, E.; Qu, D.; Huang, T.; Rizzi, N.; Boonying, W.; Krolak, D.; Ciana, P.; Woulfe, J.; Klein, C.; Slack, R.S.; et al. PINK1-mediated phosphorylation of LETM1 regulates mitochondrial calcium transport and protects neurons against mitochondrial stress. Nat. Commun. 2017, 8, 1399. [Google Scholar] [CrossRef] [PubMed]
  33. Wang, Y.; Landry, A.P.; Ding, X.H. The mitochondrial outer membrane protein mitoNEET is aredox enzyme catalyzing electron transfer from FMNH2 tooxygen or ubiquinone. J. Biol. Chem. 2017, 292, 10061–10067. [Google Scholar] [CrossRef] [Green Version]
  34. Mertins, P.; Yang, F.; Liu, T.; Mani, D.R.; Petyuk, V.A.; Gillette, M.A.; Clauser, K.R.; Qiao, J.W.; Gritsenko, M.A.; Moore, R.J.; et al. Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol. Cell. Proteom. 2014, 13, 1690–1704. [Google Scholar] [CrossRef] [Green Version]
  35. Schweppe, D.K.; Rigas, J.R.; Gerber, S.A. Quantitative phosphoproteomic profiling of human non-small cell lung cancer tumors. J. Proteom. 2013, 91, 286–296. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  36. Zhou, H.; Di Palma, S.; Preisinger, C.; Peng, M.; Polat, A.N.; Heck, A.J.; Mohammed, S. Toward a comprehensive characterization of a human cancer cell phosphoproteome. J. Proteome Res. 2013, 12, 260–271. [Google Scholar] [CrossRef]
  37. Shah, G.N.; Rubbelke, T.S.; Hendin, J.; Nguyen, H.; Waheed, A.; Shoemaker, J.D.; Sly, W.S. Targeted mutagenesis of mitochondrial carbonic anhydrases VA and VB implicates both enzymes in ammonia detoxification and glucose metabolism. Proc. Natl. Acad. Sci. USA 2013, 110, 7423–7428. [Google Scholar] [CrossRef] [Green Version]
  38. Fiore, A.D.; Supuran, C.T.; Scalonic, A.; De Simonea, G. Human carbonic anhydrases and post-translational modifications: A hidden world possibly affecting protein properties and functions. J. Enzyme Inhib. Med. Chem. 2020, 35, 1450–1461. [Google Scholar] [CrossRef] [PubMed]
  39. Kawata, T.; Shevchenko, A.; Fukuzawa, M.; Jermyn, K.A.; Totty, N.F.; Zhukovskaya, N.V.; Sterling, A.E.; Mann, M.; Williams, J.G. SH2 signaling in a lower eukaryote: A STAT protein that regulates stalk cell differentiation in Dictyostelium. Cell 1997, 89, 909–916. [Google Scholar] [CrossRef] [Green Version]
  40. Goldberg, J.M.; Manning, G.; Liu, A.; Fey, P.; Pilcher, K.E.; Xu, Y.; Smith, J.L. The Dictyostelium kinome-analysis of the protein kinases from a simple model organism. PLoS Genet. 2006, 2, e38. [Google Scholar] [CrossRef]
  41. Padrao, A.I.; Vitorino, R.; Duarte, J.A.; Ferreira, R.; Amado, F. Unraveling the phosphoproteome dynamics in mammal mitochondria from a network perspective. J. Proteome Res. 2013, 12, 4257–4267. [Google Scholar] [CrossRef] [PubMed]
  42. Nichols, J.M.E.; Paschke, P.; Peak-Chew, S.; Williams, T.D.; Tweedy, L.; Skehel, M.; Stephens, E.; Chubb, J.R.; Kay, R.R. The atypical MAP kinase ErkB transmits distinct chemotactic signals through a core signaling module. Dev. Cell 2019, 48, 491–505. [Google Scholar] [CrossRef] [PubMed]
  43. Sugden, C.; Urbaniak, M.D.; Araki, T.; Williams, J.G. The Dictyostelium prestalk inducer differentiation-inducing factor-1 (DIF-1) triggers unexpectedly complex global phosphorylation changes. Mol. Biol. Cell 2015, 26, 805–820. [Google Scholar] [CrossRef] [Green Version]
  44. Kim, L.; Harwood, A.; Kimmel, A.R. Receptor-dependent and tyrosine phosphatase-mediated inhibition of GSK3 regulates cell fate choice. Dev. Cell 2002, 3, 523–532. [Google Scholar] [CrossRef] [Green Version]
  45. Sukumaran, S.K.; Blau-Wasser, R.; Rohlfs, M.; Gallinger, C.; Schleicher, M.; Noegel, A.A. The centrosomal component CEP161 of Dictyostelium discoideum interacts with the Hippo signaling pathway. Cell Cycle 2015, 14, 1024–1035. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  46. Eichinger, L.; Bähler, M.; Dietz, M.; Eckerskorn, C.; Schleicher, M. Characterization and cloning of a Dictyostelium Ste20-like protein kinase that phosphorylates the actin-binding protein severin. J. Biol. Chem. 1998, 273, 12952–12959. [Google Scholar] [CrossRef] [Green Version]
  47. Bergeron, R.; Ren, J.M.; Cadman, K.S.; Moore, I.K.; Perret, P.; Pypaert, M.; Young, L.H.; Semenkovich, C.F.; Shulman, G.I. Chronic activation of AMP kinase results in NRF-1 activation and mitochondrial biogenesis. Am. J. Physiol. Endocrinol. Metab. 2001, 281, 1340–1346. [Google Scholar] [CrossRef] [PubMed]
  48. Nowikovsky, K.; Froschauer, E.M.; Zsurka, G.; Samaj, J.; Reipert, S.; Kolisek, M.; Wiesenberger, G.; Schweyen, R.J. The LETM1/YOL027 gene family encodes a factor of the mitochondrial K+ homeostasis with a potential role in the Wolf–Hirschhorn syndrome. J. Biol. Chem. 2004, 279, 30307–30315. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  49. Tamai, S.; Iida, H.; Yokota, S.; Sayano, T.; Kiguchiya, S.; Ishihara, N.; Hayashi, J.-I.; Mihara, K.; Oka, T. Characterization of the mitochondrial protein LETM1, which maintains the mitochondrial tubular shapes and interacts with the AAA-ATPase BCS1L. J. Cell Sci. 2008, 121, 2588–2600. [Google Scholar] [CrossRef] [Green Version]
  50. Jiang, D.; Zhao, L.; Clapham, D.E. Genome-wide RNAi screen identifies Letm1 as a mitochondrial Ca2+/H+ antiporter. Science 2009, 326, 144–147. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  51. McQuibban, A.G.; Joza, N.; Megighian, A.; Scorzeto, M.; Zanini, D.; Reipert, S.; Richter, C.; Schweyen, R.J.; Nowikovsky, K. A Drosophila mutant of LETM1, a candidate gene for seizures in Wolf–Hirschhorn syndrome. Hum. Mol. Genet. 2010, 19, 987–1000. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  52. Doonan, P.J.; Chandramoorthy, H.C.; Hoffman, N.E.; Zhang, X.; Cárdenas, C.; Shanmughapriya, S.; Rajan, S.; Vallem, S.; Chen, X.; Foskett, J.K.; et al. LETM1-dependent mitochondrial Ca2 flux modulates cellular bioenergetics and proliferation. FASEB J. 2014, 28, 4936–4949. [Google Scholar] [CrossRef] [Green Version]
  53. Shao, J.; Fu, Z.; Ji, Y.; Guan, X.; Guo, S.; Ding, Z.; Yang, X.; Cong, Y.; Shen, Y. Leucine zipper-EF-hand containing trans- membrane protein 1 (LETM1) forms a Ca2+/H+ antiporter. Sci. Rep. 2016, 6, 34174. [Google Scholar] [CrossRef] [Green Version]
  54. Frazier, A.E.; Taylor, R.D.; Mick, D.U.; Warscheid, B.; Stoepel, N.; Meyer, H.; Ryan, M.T.; Guiard, B.; Rehling, P. Mdm38 interacts with ribosomes and is a component of the mitochondrial protein export machinery. J. Cell Biol. 2006, 172, 553–564. [Google Scholar] [CrossRef] [Green Version]
  55. Bauerschmitt, H.; Mick, D.U.; Deckers, M.; Vollmer, C.; Funes, S.; Kehrein, K.; Ott, M.; Rehling, P.; Herrmann, J. Ribosome-binding proteins Mdm38 and Mba1 display overlapping functions for regulation of mitochondrial translation. Mol. Biol. Cell 2010, 21, 1937–1944. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  56. Durigon, R.; Mitchell, A.L.; Jones, A.W.E.; Manole, A.; Mennuni, M.; Hirst, E.M.A.; Houlden, H.; Maragni, G.; Lattante, S.; Doronzio, P.N.; et al. LETM1 couples mitochondrial DNA metabolism and nutrient preference. EMBO Mol. Med. 2018, 10, e8550. [Google Scholar] [CrossRef]
  57. Wiley, S.E.; Murphy, A.N.; Ross, S.A.; van der Geer, P.; Dixon, J.E. MitoNEET is an iron-containing outer mitochondrial membrane protein that regulates oxidative capacity. Proc. Natl. Acad. Sci. USA 2007, 104, 5318–5323. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  58. Li, H.; Ruan, Y.; Zhang, K.; Jian, F.; Hu, C.; Miao, L.; Gong, L.; Sun, L.; Zhang, X.; Chen, S.; et al. Mic60/Mitofilin determines MICOS assembly essential for mitochondrial dynamics and mtDNA nucleoid organization. Cell Death Differ. 2016, 23, 380–392. [Google Scholar] [CrossRef] [Green Version]
  59. Meeusen, S.; Tieu, Q.; Wong, E.; Weiss, E.; Schieltz, D.; Yates, J.R.; Nunnari, J. Mgm101p is a novel component of the mitochondrial nucleoid that binds DNA and is required for the repair of oxidatively damaged mitochondrial DNA. J. Cell Biol. 1999, 145, 291–304. [Google Scholar] [CrossRef] [Green Version]
  60. Lay, S.; Sanislav, O.; Annesley, S.J.; Fisher, P.R. Mitochondrial stress tests using Seahorse respirometry on intact Dictyostelium discoideum cells. Methods Mol. Biol. 2016, 1407, 41–61. [Google Scholar] [CrossRef]
  61. Gnad, F.; Forner, F.; Zielinska, D.F.; Birney, E.; Gunawardena, J.; Mann, M. Evolutionary constraints of phosphorylation in eukaryotes, prokaryotes, and mitochondria. Mol. Cell. Proteom. 2010, 9, 2642–2653. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  62. Kotrasova, V.; Keresztesova, B.; Ondrovicova, G.; Bauer, J.A.; Havalova, H.; Pevala, V.; Kutejova, E.; Kunova, N. Mitochondrial kinases and the role of mitochondrial protein phosphorylation in health and disease. Life 2021, 11, 82. [Google Scholar] [CrossRef] [PubMed]
  63. Frankovsky, J.; Vozarikova, V.; Nosek, J.; Tomaska, L. Mitochondrial protein phosphorylation in yeast revisited. Mitochondrion 2021, 57, 148–162. [Google Scholar] [CrossRef]
  64. Castellanos, E.; Lanning, N.J. Phosphorylation of OXPHOS machinery subunits: Functional implications in cell biology and disease. Yale J. Biol. Med. 2019, 92, 523–531. [Google Scholar]
  65. Hojlund, K.; Wrzesinski, K.; Larsen, P.M.; Fey, S.J.; Roepstorff, P.; Handberg, A.; Dela, F.; Vinten, J.; McCormack, J.G.; Reynet, C.; et al. Proteome analysis reveals phosphorylation of ATP synthase beta -subunit in human skeletal muscle and proteins with potential roles in type 2 diabetes. J. Biol. Chem. 2003, 278, 10436–10442. [Google Scholar] [CrossRef] [Green Version]
  66. Hojlund, K.; Yi, Z.; Lefort, N.; Langlais, P.; Bowen, B.; Levin, K.; Beck-Nielsen, H.; Mandarino, L.J. Human ATP synthase beta is phosphorylated at multiple sites and shows abnormal phosphorylation at specific sites in insulin-resistant muscle. Diabetologia 2010, 53, 541–551. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  67. Zhao, X.; Leon, I.R.; Bak, S.; Mogensen, M.; Wrzesinski, K.; Hojlund, K.; Jensen, O.N. Phosphoproteome analysis of functional mitochondria isolated from resting human muscle reveals extensive phosphorylation of inner membrane protein complexes and enzymes. Mol. Cell. Proteom. 2011, 10, M110.000299. [Google Scholar] [CrossRef] [Green Version]
  68. Kane, L.A.; Youngmas, M.J.; Jensen, R.E.; Van Eyk, J.E. Phosphorylation of the F1F0 ATP synthase β subunit: Functional and structural consequences in a model system. Circ. Res. 2010, 106, 504–513. [Google Scholar] [CrossRef] [Green Version]
  69. Strauss, M.; Hofhaus, G.; Schröder, R.R.; Kühlbrandt, W. Dimer ribbons of ATP synthase shape the inner mitochondrial membrane. EMBO J. 2008, 27, 1154–1160. [Google Scholar] [CrossRef] [Green Version]
  70. Bakhtiari, N.; Lai-Zhang, J.; Yao, B.; Mueller, D.M. Structure/function of the beta-barrel domain of F1-ATPase in the yeast Saccharomyces cerevisiae. J. Biol. Chem. 1999, 274, 16363–16369. [Google Scholar] [CrossRef] [Green Version]
  71. He, J.; Ford, H.C.; Carroll, J.; Douglas, C.; Gonzales, E.; Ding, S.; Fearnley, I.M.; Walker, J.E. Assembly of the membrane domain of ATP synthase in human mitochondria. Proc. Natl. Acad. Sci. USA 2018, 115, 2988–2993. [Google Scholar] [CrossRef] [Green Version]
  72. Liu, X.; Godwin, M.L.; Nowak, G. Protein kinase C-alpha inhibits the repair of oxidative phosphorylation after S-(1,2-dichlorovinyl)-L-cysteine injury in renal cells. Am. J. Physiol. Renal Physiol. 2004, 287, 64–73. [Google Scholar] [CrossRef] [Green Version]
  73. Di Pancrazio, F.; Bisetto, E.; Alverdi, V.; Mavelli, I.; Esposito, G.; Professor, G.L. Differential steady-state tyrosine phosphorylation of two oligomeric forms of mitochondrial F0F1 ATP synthase: A structural proteomic analysis. Proteomics 2006, 3, 921–926. [Google Scholar] [CrossRef]
  74. Bak, S.; Leon, I.; Jensen, O.N.; Hojlund, K. Tissue specific phosphorylation of mitochondrial proteins isolated from rat liver, heart muscle, and skeletal muscle. J. Proteome Res. 2013, 12, 4327–4339. [Google Scholar] [CrossRef]
  75. Yang, K.; Chen, Z.; Gao, J.; Shi, W.; Li, L.; Jiang, S.; Hu, H.; Liu, Z.; Xu, D.; Wu, L. The key roles of GSK-3beta in regulating mitochondrial activity. Cell Physiol. Biochem. 2017, 44, 1445–1459. [Google Scholar] [CrossRef] [PubMed]
  76. Hindi, S.M.; Sato, S.; Xiong, G.; Bohnert, K.R.; Gibb, A.A.; Gallot, Y.S.; McMillan, J.D.; Hill, B.G.; Uchida, S.; Kumar, A. TAK1 regulates skeletal muscle mass and mitochondrial function. JCI Insight 2018, 3, e98441. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  77. Momcilovic, M.; Hong, S.-P.; Carlson, M. Mammalian TAK1 activates Snf1 protein kinase in yeast and phosphorylates AMP-activated protein kinase in vitro. J. Biol. Chem. 2006, 281, 25336–25343. [Google Scholar] [CrossRef] [Green Version]
  78. Jia, J.; Bissa, B.; Brecht, L.; Allers, L.; Choi, S.W.; Gu, Y.; Zbinden, M.; Burge, M.R.; Timmins, G.; Hallows, K.; et al. AMPK, a regulator of metabolism and autophagy, is activated by lysosomal damage via a novel galectin-directed ubiquitin signal transduction system. Mol. Cell 2020, 77, 951–969. [Google Scholar] [CrossRef]
  79. Mia, S.; Castor, T.; Musculus, K.; Voelkl, J.; Alesutan, I.; Lang, F. Role of AMP-activated protein kinase α1 in angiotensin-II-induced renal Tgfβ-activated kinase 1 activation. Biochem. Biophys. Res. Commun. 2016, 476, 267–272. [Google Scholar] [CrossRef] [PubMed]
  80. Kim, S.Y.; Jeong, S.; Jung, E.; Baik, K.-H.; Chang, M.H.; Kim, S.A.; Shim, J.-H.; Chun, E.; Lee, K.-Y. AMP-activated protein kinase-α1 as an activating kinase of TGF-β-activated kinase 1 has a key role in inflammatory signals. Cell Death Dis. 2012, 3, e357. [Google Scholar] [CrossRef] [Green Version]
  81. Mahapatra, G.; Varughese, A.; Ji, Q.; Lee, I.; Liu, J.; Vaishnav, A.; Sinkler, C.; Kapralov, A.A.; Moraes, C.T.; Sanderson, T.H.; et al. Phosphorylation of cytochrome c threonine 28 regulates electron transport chain activity in kidney: Implications for Amp kinase. J. Biol. Chem. 2017, 292, 64–79. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  82. Hardie, D.G.; Schaffer, B.E.; Brunet, A. AMPK: An energy-sensing pathway with multiple inputs. Trends Cell Biol. 2016, 26, 190–201. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  83. Hoffman, N.J.; Parker, B.L.; Chaudhuri, R.; Fisher-Wellman, K.H.; Kleinert, M.; Humphrey, S.J.; Yang, P.; Holliday, M.; Trefely, S.; Fazakerley, D.J.; et al. Global phosphoproteomic analysis of human skeletal muscle reveals a network of exercise-regulated kinases and AMPK substrates. Cell Metab. 2015, 22, 922–935. [Google Scholar] [CrossRef] [Green Version]
  84. Liu, Y.; Jin, M.; Wang, Y.; Zhu, J.; Tan, R.; Zhao, J.; Ji, X.; Jin, C.; Jia, Y.; Ren, T.; et al. MCU-induced mitochondrial calcium uptake promotes mitochondrial biogenesis and colorectal cancer growth. Sig. Transduct. Target Ther. 2020, 5, 59. [Google Scholar] [CrossRef] [PubMed]
  85. Ohshima, Y.; Takata, N.; Suzuki-Karasaki, M.; Yoshida, Y.; Tokuhashi, Y.; Suzuki-Karasaki, Y. Disrupting mitochondrial Ca2+ homeostasis causes tumor-selective TRAIL sensitization through mitochondrial network abnormalities. Int. J. Oncol. 2017, 51, 1146–1158. [Google Scholar] [CrossRef] [PubMed]
  86. Palm, W.; Thompson, C.B. Nutrient acquisition strategies of mammalian cells. Nature 2017, 546, 234–242. [Google Scholar] [CrossRef] [PubMed]
  87. Gonzalez, A.; Hall, M.N.; Lin, S.-C.; Hardie, D.G. AMPK and TOR: The Yin and Yang of cellular nutrient sensing and growth control. Cell Metab. 2020, 31, 472–492. [Google Scholar] [CrossRef]
  88. Loewith, R.; Jacinto, E.; Wullschleger, S.; Lorberg, A.; Crespo, J.L.; Bonenfant, D.; Oppliger, W.; Jenoe, P.; Hall, M.N. Two TOR complexes, only one of which is rapamycin sensi- tive, have distinct roles in cell growth control. Mol. Cell 2002, 10, 457–468. [Google Scholar] [CrossRef]
  89. Jaiswal, P.; Majithia, A.R.; Rosel, D.; Liao, X.-H.; Khurana, T.; Kimmel, A.R. Integrated actions of mTOR complexes 1 and 2 for growth and development of Dictyostelium. Int. J. Dev. Biol. 2019, 63, 521–527. [Google Scholar] [CrossRef] [Green Version]
  90. Lee, S.; Comer, F.I.; Sasaki, A.; McLeod, I.X.; Duong, Y.; Okumura, K.; Yates, J.R., III; Parent, C.A.; Firtel, R.A. TOR complex 2 integrates cell movement during chemotaxis and signal relay in Dictyostelium. Mol. Biol. Cell 2005, 16, 4572–4583. [Google Scholar] [CrossRef] [Green Version]
  91. Gwinn, D.M.; Shackelford, D.B.; Egan, D.F.; Mihaylova, M.M.; Mery, A.; Vasquez, D.S.; Turk, B.E.; Shaw, R.J. AMPK phosphorylation of raptor mediates a metabolic check-point. Mol. Cell 2008, 30, 214–226. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  92. Nada, S.; Hondo, A.; Kasai, A.; Koike, M.; Saito, K.; Uchiyama, Y.; Okada, M. The novel lipid raft adaptor p18 controls endosome dynamics by anchoring the MEK-ERK pathway to late endosomes. EMBO J. 2009, 28, 477–489. [Google Scholar] [CrossRef] [Green Version]
  93. Sancak, Y.; Bar-Peled, L.; Zoncu, R.; Markhard, A.L.; Nada, S.; Sabatini, D.M. Ragulator-Rag complex targets mTORC1 to the lysosomal sur- face and is necessary for its activation by amino acids. Cell 2010, 141, 290–303. [Google Scholar] [CrossRef] [Green Version]
  94. Zhang, C.-S.; Jiang, B.; Li, M.; Zhu, M.; Peng, Y.; Zhang, Y.-L.; Wu, Y.-Q.; Li, T.Y.; Liang, Y.; Lu, Z.; et al. The Lysosomal v-ATPase-Ragulator complex is a common activator for AMPK and mTORC1, acting as a switch between catabolism and anabolism. Cell Metab. 2014, 20, 526–540. [Google Scholar] [CrossRef] [Green Version]
  95. Thomas, J.D.; Zhang, Y.; Wie, Y.; Cho, J.-H.; Morris, L.E.; Wang, H.-Y.; Zheng, X.F.S. Rab1A is an mTORC1 activator and a colorectal oncogene. Cancer Cell 2014, 26, 754–769. [Google Scholar] [CrossRef] [Green Version]
  96. Levin, R.S.; Hertz, N.T.; Burlingame, A.L.; Shokat, K.M.; Mukherjee, S. Innate immunity kinate TAK1 phosphorylates Rab1 on a hotspot for posttranslational modifications by host and pathogen. Proc. Natl. Acad. Sci. USA 2016, 113, 4776–4783. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  97. Jaiswal, P.; Kimmel, A.R. mTORC1/AMPK responses define a core gene set for developmental cell fate switching. BMC Biol. 2019, 17, 58. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  98. Missailidis, D.; Annesley, S.J.; Allan, C.Y.; Sanislav, O.; Lidbury, B.A.; Lewis, D.P.; Fisher, P.R. An isolated Complex V inefficiency and dysregulated mitochondrial function in immortalized lymphocytes from ME/CFS patients. Int. J. Mol. Sci. 2020, 21, 1074. [Google Scholar] [CrossRef] [Green Version]
  99. Missailidis, D.; Sanislav, O.; Allan, C.Y.; Smith, P.K.; Annesley, S.J.; Fisher, P.R. Dysregulated provision of oxidisable substrates to the mitochondria in ME/CFS lymphoblasts. Int. J. Mol. Sci. 2021, 22, 2046. [Google Scholar] [CrossRef]
  100. Watts, D.J.; Ashworth, J.M. Growth of myxameobae of the cellular slime mould Dictyostelium discoideum in axenic culture. Biochem. J. 1970, 119, 171–174. [Google Scholar] [CrossRef] [Green Version]
  101. Lowry, O.H.; Rosenbrough, N.J.; Farr, A.L.; Randall, R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193, 265–275. [Google Scholar] [CrossRef]
  102. Boersema, P.J.; Mohammed, S.; Heck, A.J. Phosphopeptide fragmentation and analysis by mass spectrometry. J. Mass Spectrom. 2009, 44, 861–878. [Google Scholar] [CrossRef] [PubMed]
  103. Zhou, H.; Ye, M.; Dong, J.; Corradini, E.; Cristobal, A.; Heck, A.J.; Zou, H.; Mohammed, S. Robust phosphoproteome enrichment using monodisperse microsphere-based immobilized titanium (IV) ion affinity chromatography. Nat. Protoc. 2013, 8, 461–480. [Google Scholar] [CrossRef]
  104. Laemmli, U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227, 680–685. [Google Scholar] [CrossRef] [PubMed]
  105. Czarna, M.; Mathy, G.; Mac’Cord, A.; Dobson, R.; Jarmuszkiewicz, W.; Sluse-Goffart, C.M.; Leprince, P.; De Pauw, E.; Sluse, F.E. Dynamics of the Dictyostelium discoideum mitochondrial proteome during vegetative growth, starvation and early stages of development. Proteomics 2010, 10, 6–22. [Google Scholar] [CrossRef]
  106. Dyballa, N.; Metzger, S. Fast and sensitive colloidal Coomassie G-250 staining for proteins in polyacrylamide gels. J. Vis. Exp. 2009, 30, e1431. [Google Scholar] [CrossRef] [PubMed]
Ijms 22 11675 g001 550
Figure 1. Experimental workflow used in this study. (A) Vegetatively growing Dictyostelium discoideum wild-type (WT) and AMPKα-overexpressing (HPF444) cells were harvested at the exponential phase of growth and subjected to isolation and purification of mitochondria by differential centrifugation and sucrose density gradient centrifugation, respectively; (B) purified mitochondria were subjected to solubilization and tryptic digestion. Phosphopeptides were enriched via immobilized titanium (IV) ion affinity chromatography (Ti4+-IMAC) and identified by LC-MS/MS; (C) purified mitochondrial fractions were solubilized and resolved by 2D-PAGE (IEF/SDS-PAGE) electrophoresis. Proteins displaying a significant difference in abundance were picked from the gels, designed for in-gel tryptic digestion and peptide identification via MS/MS. More details on the survey design of the experiment are given in the Material and Methods as well as Results sections. Created with BioRender.com.
Figure 1. Experimental workflow used in this study. (A) Vegetatively growing Dictyostelium discoideum wild-type (WT) and AMPKα-overexpressing (HPF444) cells were harvested at the exponential phase of growth and subjected to isolation and purification of mitochondria by differential centrifugation and sucrose density gradient centrifugation, respectively; (B) purified mitochondria were subjected to solubilization and tryptic digestion. Phosphopeptides were enriched via immobilized titanium (IV) ion affinity chromatography (Ti4+-IMAC) and identified by LC-MS/MS; (C) purified mitochondrial fractions were solubilized and resolved by 2D-PAGE (IEF/SDS-PAGE) electrophoresis. Proteins displaying a significant difference in abundance were picked from the gels, designed for in-gel tryptic digestion and peptide identification via MS/MS. More details on the survey design of the experiment are given in the Material and Methods as well as Results sections. Created with BioRender.com.
Ijms 22 11675 g001
Ijms 22 11675 g002 550
Figure 2. Phosphoprotein (Pro-Q Diamond) and total protein (Sypro-Ruby) 1-D SDS-PAGE gel stain of total mitochondrial proteins isolated from vegetative cells of D. discoideum WT and HPF444 Scheme. (A) A total of 100 µg of purified mitochondrial proteins isolated from vegetative cells from the exponential (E) and stationary (S) phases of growth (WT_E, WT_S; HPF444_E, HPF444_S) were separated by 12% SDS-PAGE and stained with Pro-Q Diamond (Thermo Fisher Scientific, Waltham, MA, USA) to selectively visualize phosphorylated proteins; (B) The gel stained with Pro-Q Diamond was further stained with Sypro Ruby (Thermo Fisher Scientific, Waltham, MA, USA) to detect total mitochondrial proteins. The Unstained Protein Molecular Weight Marker (Thermo Fisher Scientific, Waltham, MA, USA) was used. The arrows indicate the phosphoproteins that show different intensity in the mutant in comparison to the WT mitochondria.
Figure 2. Phosphoprotein (Pro-Q Diamond) and total protein (Sypro-Ruby) 1-D SDS-PAGE gel stain of total mitochondrial proteins isolated from vegetative cells of D. discoideum WT and HPF444 Scheme. (A) A total of 100 µg of purified mitochondrial proteins isolated from vegetative cells from the exponential (E) and stationary (S) phases of growth (WT_E, WT_S; HPF444_E, HPF444_S) were separated by 12% SDS-PAGE and stained with Pro-Q Diamond (Thermo Fisher Scientific, Waltham, MA, USA) to selectively visualize phosphorylated proteins; (B) The gel stained with Pro-Q Diamond was further stained with Sypro Ruby (Thermo Fisher Scientific, Waltham, MA, USA) to detect total mitochondrial proteins. The Unstained Protein Molecular Weight Marker (Thermo Fisher Scientific, Waltham, MA, USA) was used. The arrows indicate the phosphoproteins that show different intensity in the mutant in comparison to the WT mitochondria.
Ijms 22 11675 g002
Ijms 22 11675 g003 550
Figure 3. Profiling phosphoproteins of D. discoideum mitochondria. (A) Proportion and functional categories of identified phosphoproteins in mitochondrial preparations; (B) distribution of serine (pSer), threonine (pThr), and tyrosine (pTyr) phosphorylation sites in identified proteins; (C) the number of non-redundant phosphoproteins, phosphopeptides and phosphorylation sites identified in mitochondrial preparations from D. discoideum WT and HPF444 strains.
Figure 3. Profiling phosphoproteins of D. discoideum mitochondria. (A) Proportion and functional categories of identified phosphoproteins in mitochondrial preparations; (B) distribution of serine (pSer), threonine (pThr), and tyrosine (pTyr) phosphorylation sites in identified proteins; (C) the number of non-redundant phosphoproteins, phosphopeptides and phosphorylation sites identified in mitochondrial preparations from D. discoideum WT and HPF444 strains.
Ijms 22 11675 g003
Ijms 22 11675 g004 550
Figure 4. (A) Representative Coomassie brilliant blue (CBB)-stained 2-D PAGE gels of total mitochondrial proteins isolated from exponentially growing vegetative cells of D. discoideum WT and HPF444 strains. A total of 400 µg of purified mitochondrial proteins was separated by 2-D PAGE and stained by colloidal CBB. Three independent biological replicates of each strain were analysed using Delta 2-D Software 4.2 (DECODON, Greifswald, Germany); (B) Relative levels of mitochondrial proteins identified by 2-D PAGE analysis in D. discoideum HPF444 strain compared to WT cells. The relative abundance of proteins is expressed as Log2 ratios. In italics, gene name of a differing protein is presented. Full names of proteins and detailed statistical analysis are given in Table S4.
Figure 4. (A) Representative Coomassie brilliant blue (CBB)-stained 2-D PAGE gels of total mitochondrial proteins isolated from exponentially growing vegetative cells of D. discoideum WT and HPF444 strains. A total of 400 µg of purified mitochondrial proteins was separated by 2-D PAGE and stained by colloidal CBB. Three independent biological replicates of each strain were analysed using Delta 2-D Software 4.2 (DECODON, Greifswald, Germany); (B) Relative levels of mitochondrial proteins identified by 2-D PAGE analysis in D. discoideum HPF444 strain compared to WT cells. The relative abundance of proteins is expressed as Log2 ratios. In italics, gene name of a differing protein is presented. Full names of proteins and detailed statistical analysis are given in Table S4.
Ijms 22 11675 g004
Ijms 22 11675 g005a 550Ijms 22 11675 g005b 550
Figure 5. Effect of AMPK expression levels on mitochondrial respiratory function. Respiratory O2 consumption rates (pmol/min) were assayed using 1 × 105 amoebae per well of the wild-type parental strain (A × 2) or strains stably transformed with either an AMPK antisense-inhibition or overexpression construct. A predetermined convention was followed using the copy number of the construct as an expression index (negative numbers for antisense inhibition and positive numbers for overexpression). To estimate the contribution of the ATP-linked oxygen consumption rate (OCR) (C) and non-ATP-linked OCR (proton leak) (D) to the basal respiratory rate (A), N,N′-dicyclohexylcarbodimide (DCCD) was added to inhibit ATP synthesis at Complex V. Subsequently, a protonophore (uncoupler) carbonyl cyanide 3-chlorophenol hydrazone (CCCP) was added to determine the maximum OCR (B). The subsequent addition of rotenone (Complex I inhibitor) and either antimycin A (Complex III inhibitor) or benzohydroxamic acid (BHAM, AOX inhibitor) allowed to estimate the contribution of Complex I (E) and Complex II (Complex II/III + Complex II/AOX) (F) to the maximum OCR. The slope of the regression line was positive as assumed in all cases, reaching statistical significance in the case of the basal OCR and the maximum uncoupled OCR.
Figure 5. Effect of AMPK expression levels on mitochondrial respiratory function. Respiratory O2 consumption rates (pmol/min) were assayed using 1 × 105 amoebae per well of the wild-type parental strain (A × 2) or strains stably transformed with either an AMPK antisense-inhibition or overexpression construct. A predetermined convention was followed using the copy number of the construct as an expression index (negative numbers for antisense inhibition and positive numbers for overexpression). To estimate the contribution of the ATP-linked oxygen consumption rate (OCR) (C) and non-ATP-linked OCR (proton leak) (D) to the basal respiratory rate (A), N,N′-dicyclohexylcarbodimide (DCCD) was added to inhibit ATP synthesis at Complex V. Subsequently, a protonophore (uncoupler) carbonyl cyanide 3-chlorophenol hydrazone (CCCP) was added to determine the maximum OCR (B). The subsequent addition of rotenone (Complex I inhibitor) and either antimycin A (Complex III inhibitor) or benzohydroxamic acid (BHAM, AOX inhibitor) allowed to estimate the contribution of Complex I (E) and Complex II (Complex II/III + Complex II/AOX) (F) to the maximum OCR. The slope of the regression line was positive as assumed in all cases, reaching statistical significance in the case of the basal OCR and the maximum uncoupled OCR.
Ijms 22 11675 g005aIjms 22 11675 g005b
Ijms 22 11675 g006 550
Figure 6. A hypothetical scenario of the events leading to enhanced mitochondrial biogenesis and reduced growth rate of D. discoideum vegetative cells in the presence of chronically active catalytic AMPKα subunit. The directions of short green, red and orange arrows specify either change in the protein abundance/phosphorylation level or direction of a specific process in the presence of chronically active AMPKα subunit. Black lines ending with arrowheads indicate activating effects, while perpendicular lines indicate inhibiting effects. Black dotted lines indicate hypothetical processes. Chronically active AMPK leads to the inhibition of the mTORC1 pathway via dephosphorylation-dependent events including the SHKA-Rab1A-mTORC1 route and/or the AMPK-LAMTOR1-mTORC1 pathway, which in consequence results in a decrease in cell growth and division. Enhanced mitochondrial biogenesis is induced by not yet identified mitochondrial protein target which upon direct or indirect phosphorylation by AMPK leads to dramatic changes in the abundance and/or phosphorylation-dependent activity of mitochondrial proteins involved in energy metabolism, protein synthesis and membrane biogenesis. This in turn causes the presence of increased mitochondrial mass and level of cellular ATP. SHKA, dual-specificity protein kinase SHKA; Ras1A, Ras-related protein Ras1A; mTORC1, mechanistic target of rapamycin complex 1; LAMTOR1, Ragulator complex protein Lamtor1. Created with BioRender.com.
Figure 6. A hypothetical scenario of the events leading to enhanced mitochondrial biogenesis and reduced growth rate of D. discoideum vegetative cells in the presence of chronically active catalytic AMPKα subunit. The directions of short green, red and orange arrows specify either change in the protein abundance/phosphorylation level or direction of a specific process in the presence of chronically active AMPKα subunit. Black lines ending with arrowheads indicate activating effects, while perpendicular lines indicate inhibiting effects. Black dotted lines indicate hypothetical processes. Chronically active AMPK leads to the inhibition of the mTORC1 pathway via dephosphorylation-dependent events including the SHKA-Rab1A-mTORC1 route and/or the AMPK-LAMTOR1-mTORC1 pathway, which in consequence results in a decrease in cell growth and division. Enhanced mitochondrial biogenesis is induced by not yet identified mitochondrial protein target which upon direct or indirect phosphorylation by AMPK leads to dramatic changes in the abundance and/or phosphorylation-dependent activity of mitochondrial proteins involved in energy metabolism, protein synthesis and membrane biogenesis. This in turn causes the presence of increased mitochondrial mass and level of cellular ATP. SHKA, dual-specificity protein kinase SHKA; Ras1A, Ras-related protein Ras1A; mTORC1, mechanistic target of rapamycin complex 1; LAMTOR1, Ragulator complex protein Lamtor1. Created with BioRender.com.
Ijms 22 11675 g006
Table
Table 1. Phosphorylated mitochondrial and mitochondria-associated proteins identified in mitochondrial preparations from D. discoideum wild-type (WT) and AMPKα-overexpressing (HPF444) strain. UniProt, Universal Protein Resource database, protein ID; DictyBase, Dictyostelium discoideum genome database, protein ID; Protein, protein name (in brackets, gene name); Phosphopeptide(s), identified phosphorylated peptide sequence; “marked in red colour”, phosphorylated amino acid residue within the identified peptide; Phosphorylation site, phosphorylated amino acid in the protein sequence (Ser, serine; Thr, threonine; Tyr, tyrosine).
Table 1. Phosphorylated mitochondrial and mitochondria-associated proteins identified in mitochondrial preparations from D. discoideum wild-type (WT) and AMPKα-overexpressing (HPF444) strain. UniProt, Universal Protein Resource database, protein ID; DictyBase, Dictyostelium discoideum genome database, protein ID; Protein, protein name (in brackets, gene name); Phosphopeptide(s), identified phosphorylated peptide sequence; “marked in red colour”, phosphorylated amino acid residue within the identified peptide; Phosphorylation site, phosphorylated amino acid in the protein sequence (Ser, serine; Thr, threonine; Tyr, tyrosine).
UniProtDictyBaseProtein Phosphopeptide(s)Phosphorylation Site
OXPHOS
Q9U3X4DDB0214886Succinate dehydrogenase (sdhA)gEGGYLLNSsGERSer-300
Q54D07DDB0238603Cytochrome c1, heme protein (cyc1)amAADtTVmDGPDSEGDmFER
amAADTTVmDGPDsEGDmFER		Thr-104
Ser-112
Q1ZXP3DDB0233077Cytochrome b-c1 complex, subunit 6 (uqcrh)gPIQEGcAsGcEk
vkGPIQEGcAsGcEk		Ser-18
Q54V76DDB0267111Cytochrome b-c1 complex, subunit 8 (uqcrq)qITYSVsPFQQkSer-17
Q54NW9DDB0238608Cytochrome b-c1 complex, subunit Rieske (ucr)fITsDkIIVGDESer-206
P30815DDB0214995Cytochrome c oxidase, subunit 4 (cxdA)vGsPEFDkSer-55
P29505DDB0191104Cytochrome c oxidase, subunit 5 (cxeA)hISsEGEVmYYSer-113
A9CLV8DDB0350620ATP synthase, subunit 4 (atp4)dLsSDEITNSSTk
dLSsDEITNSSTk
dLSSDEItNSSTk		Ser-108
Ser-109
Thr-113
Q54DF1DDB0237782ATP synthase, subunit gamma (atp5C1)vLGVVETADAFNTAtEPIEDRThr-85
Q54RA8DDB0266798ATP synthase, subunit O (OSCP) (atp5O)tALEGDIDNsEk
yLtLDESkN		Ser-133
Thr-290
Q55CS9DDB0233951ATP synthase, subunit beta (atp5B)sLLDkESNEESTEVDYSk
sLLDkEsNEESTEVDYSk
sLLDkESNEEsTEVDYSk
sLLDkESNEEStEVDYSk
vIEDLNNPsLk
aPPPFADLAPSAsILETGIk		Ser-58
Ser-64
Ser-68
Thr-69
Ser-128
Ser-231
OXPHOS complex regulation and assembly
Q54ID0DDB0305161Cytochrome c oxidase copper chaperone (cox17)sIAETNTTTEVAAPkSer-2
Q9GSE7DDB0216175F1F0-ATPase putative regulatory protein (if1)kAGSQPTPNASSSANNskSer-81
Genome repair & maintenance
Q8MYF0DDB0304673Mitochondrial genome maintenance protein (mgm101)iTEQQDDsEDIDIDDVVPPQLkSer-315
Protein synthesis, folding & stabilization
Q54WN8DDB0304956Uncharacterized protein; probable mitochondrial small ribosomal subunit (DDB_G0279527)eIIDQNPNDStDmPITRThr-846
Q54CA5DDB0306787S5 DRBM domain-containing protein, mitochondrial small ribosomal subunittIFEDGELDTPsVNSIR
tIFEDGELDTPSVNsIR
lGTVEHEELtFDHEk
rFDEDYAEEsEILSQFSk
eLsEYEEVIHQR		Ser-802
Ser-805
Thr-915
Ser-1006
Ser-1587
Q55GH1DDB0306542Protein similar to yeast tRNA threonylcarbamoyladenosine dehydratase 2 (DDB_G0268496)sLNGGGGGGDDDGDNNNSsPSNQHIDkSer-51
Q54F93DDB0232199Mitochondrial-processing peptidase subunit alpha-2 (mppA)vTFGNDESSTSIsNETAQYIGGESLk
vTFGNDESSTSISNETAQYIGGESLkYSSGNsk		Ser-235
Ser-254
Q8I0H7DDB0215366Heat shock 70 kDa protein, mitochondrial (mhsp70)dNTTEAEFtEkkThr-655
Q8MPA5DDB0232124Heat shock protein, Hsp20 domain-containing protein (hspG7)sSTsPSSSTLDSkSer-96
C7G004DDB0304476Heat shock protein, DnaJ family protein (DDB_G0304475)yIDNLIIPSSSSsDSGSGSGGSk
yIDNLIIPSSSSSDsGSGSGGSk
yIDNLIIPSSSSSDSGSGSGGsk		Ser-213
Ser-215
Ser-222
Q54Q31DDB0232062Prohibitin-2 (phbB)sIsSLTGSkSer-91
Transport
Q01501DDB0185213Mitochondrial outer membrane protein porin (porA)yGsIVAVTDIk
qILLSTLYTATsk		Ser-47
Ser-191
O97470DDB0201558Mitochondrial substrate carrier family protein ANT; ADP/ATP carrier protein (ancA)dsLIGGTAGGVSk
lLLQVQsASTQIAADk
lLLQVQSAsTQIAADk
lLLQVQSAStQIAADk
lAADVGtGSAR
lAADVGTGsAR
lmGFEGGVGsE		Ser-16
Ser-44
Ser-46
Thr-47
Thr-150
Ser-152
Ser-308
Q54BF6DDB0233888Mitochondrial substrate carrier family protein N (mcfN)aGDLtPSLFLk Thr-6
Q54H87DDB0346938Uncharacterized protein (similar to S. cerevisiae mitochondrial phosphate transport protein PHO88m) (DDB_G0289621)vTEINEsESSSEESEkEEkSer-216
Q86AV5DDB0234131Mitochondrial substrate carrier family protein X (mcfX)gLSsNLIGIIPEkSer-87
Q54Y17DDB0306880LETM1 and EF-hand domain-containing protein (DDB_G0278471)sGQtVTSDEVLkThr-282
Metabolism
Q55GD7DDB0306487CDGSH iron-sulfur domain-containing protein (ortholog of human CISD3), similar to mitoNEET-related protein 2 (DDB_G0267712)yNEETGLNDsPLk
yNEETGLNDsPLkVEk
kYNEETGLNDsPLk		Ser-75
Q555A3DDB0203193Carbonic anhydrase (DDB_G0274643)lkENISLSTsN
lkENISLStSN		Ser-273
Thr-272
Q55BA8DDB0215348Probable calnexin (cnxA)eSVSIQDkPTIEsEESDESDEDNETTkk
eSVSIQDkPTIESEEsDESDEDNETTk eSVSIQDkPTIESEESDEsDEDNETTk		Ser-510
Ser-513
Ser-516
Signalling
P51136DDB0185150Glycogen synthase kinase-3 (gskA)gETNVsYIcSR
gETNVSyIcSR
iLIkGETNVSyIcSR		Ser-213
Tyr-214
O61122DDB0191176Severin kinase (svkA)sLsNSSQTTPVkSer-375
Q54RB7DDB0191149Dual specificity protein kinase SHKA (shkA)aQLSGyINTyr-525
Q54U31DDB0230122Dual specificity protein kinase SHKD (shkD)fTQETFNPyDPYTNTyr-739
O00910DDB0215388Signal transducer and activator of transcription A (dstA)rTAPVPVGGyEPLNSTyr-702
Q1ZXA8DDB0231625Protein similar to human Ragulator complex protein LAMTOR1 (DDB_G0292160)nQASSSQQPSSSQtPSk
nQASSSQQPSSSQTPsk
dSEEQPQEVSYsQmR
ecGELVVFFGNsLk		Thr-34
Ser-36
Ser-56
Ser-172
P34139DDB0191476Ras-related protein Rab1A (rab1A)tITSsYYRSer-76
Table
Table 2. Kinases identified in mitochondrial preparations from D. discoideum WT and HPF444 strains. UniProt, Universal Protein Resource database; DictyBase, Dictyostelium discoideum genome database; Protein, protein name; Mitochondrial preparations, number of mitochondrial preparations in which a given kinase and its phosphorylation site were identified.
Table 2. Kinases identified in mitochondrial preparations from D. discoideum WT and HPF444 strains. UniProt, Universal Protein Resource database; DictyBase, Dictyostelium discoideum genome database; Protein, protein name; Mitochondrial preparations, number of mitochondrial preparations in which a given kinase and its phosphorylation site were identified.
UniProtDictyBaseProteinKinase GroupMitochondrial Preparations
P51136DDB0185150Glycogen synthase kinase-3 CMGC kinases2
O61122DDB0191176Severin kinase STE kinases2
Q54RB7DDB0191149Dual specificity protein kinase SHKA TKL kinases3
Q54U31DDB0230122Dual specificity protein kinase SHKD TKL kinases 1
Table
Table 3. Differentially phosphorylated proteins identified in mitochondrial preparations from the D. discoideum HPF444 strain in comparison to WT in at least two biological replicates or two peptides. P-site, phosphorylation site (number of phosphorylated amino acid residue within the identified peptide). Detailed quantitative analysis is presented in Table S3.
Table 3. Differentially phosphorylated proteins identified in mitochondrial preparations from the D. discoideum HPF444 strain in comparison to WT in at least two biological replicates or two peptides. P-site, phosphorylation site (number of phosphorylated amino acid residue within the identified peptide). Detailed quantitative analysis is presented in Table S3.
DictyBaseProteinP-Site
Proteins with up-regulated phosphorylation
DDB0306880LETM1 and EF-hand domain-containing proteinThr-282
DDB0306787S5 DRBM domain-containing proteinSer-1587
DDB0306113Uncharacterized proteinThr-65
DDB0306695Uncharacterized proteinThr-367
Proteins with down-regulated phosphorylation
DDB0238603Cytochrome c1, heme proteinSer-112
DDB0237782ATP synthase, subunit gammaThr-85
DDB0233951ATP synthase, subunit betaThr-69
DDB0215366Heat shock 70 kDa protein, mitochondrialThr-655
DDB0304476Heat shock protein, DnaJ family proteinSer-213
DDB0201558Mitochondrial substrate carrier family protein ANTSer-152, 308
DDB0234131Mitochondrial substrate carrier family protein XSer-87
DDB0306487Similar to mitoNEET-related protein 2Ser-75
DDB0215348Probable calnexinSer-513
DDB0191149Dual specificity protein kinase SHKATyr-525
DDB0231625Protein similar to human Ragulator complex protein LAMTOR1Thr-34, Ser-56, 172
DDB0191476Ras-related protein Rab-1ASer-76
DDB0304899Uncharacterized protein Ser-290
DDB0347754Uncharacterized protein Ser-106, 107
DDB0305799Uncharacterized proteinSer-61, 536
DDB0302557Uncharacterized proteinThr-52
DDB0307109Uncharacterized proteinSer-647, 648, 650
DDB0306527Uncharacterized proteinSer-314
DDB0346952Uncharacterized proteinSer-230
DDB0232257Uncharacterized proteinSer-473
DDB0306348Uncharacterized proteinSer-128, Thr-130
DDB0346952Uncharacterized proteinSer-230
DDB0307677Uncharacterized proteinSer-301
DDB0306179Uncharacterized proteinSer-333
DDB0191444Myosin-2 heavy chainSer-1636, 1637
DDB0191351Myosin IB heavy chainTyr-334
DDB0185146Myosin regulatory light chainSer-14
DDB0214946Probable ATPase, P-type ATPaseSer-22
DDB0232252Crt homolog 3Ser-438
DDB0191505Vacuolin-ASer-14
DDB0234063Phospholipid-translocating ATPase Ser-86
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Heidorn-Czarna, M.; Heidorn, H.-M.; Fernando, S.; Sanislav, O.; Jarmuszkiewicz, W.; Mutzel, R.; Fisher, P.R. Chronic Activation of AMPK Induces Mitochondrial Biogenesis through Differential Phosphorylation and Abundance of Mitochondrial Proteins in Dictyostelium discoideum. Int. J. Mol. Sci. 2021, 22, 11675. https://doi.org/10.3390/ijms222111675

AMA Style

Heidorn-Czarna M, Heidorn H-M, Fernando S, Sanislav O, Jarmuszkiewicz W, Mutzel R, Fisher PR. Chronic Activation of AMPK Induces Mitochondrial Biogenesis through Differential Phosphorylation and Abundance of Mitochondrial Proteins in Dictyostelium discoideum. International Journal of Molecular Sciences. 2021; 22(21):11675. https://doi.org/10.3390/ijms222111675

Chicago/Turabian Style

Heidorn-Czarna, Malgorzata, Herbert-Michael Heidorn, Sanjanie Fernando, Oana Sanislav, Wieslawa Jarmuszkiewicz, Rupert Mutzel, and Paul R. Fisher. 2021. "Chronic Activation of AMPK Induces Mitochondrial Biogenesis through Differential Phosphorylation and Abundance of Mitochondrial Proteins in Dictyostelium discoideum" International Journal of Molecular Sciences 22, no. 21: 11675. https://doi.org/10.3390/ijms222111675

APA Style

Heidorn-Czarna, M., Heidorn, H. -M., Fernando, S., Sanislav, O., Jarmuszkiewicz, W., Mutzel, R., & Fisher, P. R. (2021). Chronic Activation of AMPK Induces Mitochondrial Biogenesis through Differential Phosphorylation and Abundance of Mitochondrial Proteins in Dictyostelium discoideum. International Journal of Molecular Sciences, 22(21), 11675. https://doi.org/10.3390/ijms222111675

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop